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Identifying Genetic Variants and Characterizing Their Role in Clubfoot 
Katelyn S. Weymouth 
Advisor: Jacqueline T. Hecht, Ph.D. 
 
Clubfoot is a common, complex birth defect affecting 4,000 newborns in the United 
States and 135,000 world-wide each year.  The clubfoot deformity is characterized by 
inward and rigid downward displacement of one or both feet, along with persistent calf 
muscle hypoplasia.  Despite strong evidence for a genetic liability, there is a limited 
understanding of the genetic and environmental factors contributing to the etiology of 
clubfoot.  The studies described in this dissertation were performed to identify variants 
and/or genes associated with clubfoot. Genome-wide linkage scan performed on ten 
multiplex clubfoot families identified seven new chromosomal regions that provide new 
areas to search for clubfoot genes. Troponin C (TNNC2) the strongest candidate gene, 
located in 20q12-q13.11, is involved in muscle contraction.  Exon sequencing of TNNC2 did 
not identify any novel coding variants. Interrogation of fifteen muscle contraction genes 
found strong associations with SNPs located in potential regulatory regions of TPM1 
(rs4075583 and rs3805965), TPM2 (rs2025126 and rs2145925) and TNNC2 (rs383112 and 
rs437122).  In previous studies, a strong association was found with rs3801776 located in 
the basal promoter of HOXA9, a gene also involved in muscle development and patterning.  
Altogether, this data suggests that SNPs located in potential regulatory regions of genes 
involved in muscle development and function could alter transcription factor binding leading 
to changes in gene expression. Functional analysis of 3801776/HOXA9, rs2025126/TPM2 
and rs2145925/TPM2 showed altered protein binding, which significantly influenced 
promoter activity.  Although the ancestral allele (G) of rs4075583/TPM1 creates a DNA-
viii 
 
protein complex, it did not affect TPM1 promoter activity.  However and importantly, in the 
context of a haplotype, rs4075583/G significantly decreased TPM1 promoter activity.  These 
results suggest dysregulation of multiple skeletal muscle genes, TPM1, TPM2, TNNC2 and 
HOXA9, working in concert may contribute to clubfoot.  However, specific allelic 
combinations involving these four regulatory SNPs did not confer a significantly higher risk 
for clubfoot.  Other combinations of these variants are being evaluated.  Moreover, these 
variants may interact with yet to be discovered variants in other genes to confer a higher 
clubfoot risk.   Collectively, we show novel evidence for the role of skeletal muscle genes in 
clubfoot indicating that there are multiple genetic factors contributing to this complex birth 
defect.  
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1.0  Introduction 
 Idiopathic congential talipes equinovarus, more commonly referred to as clubfoot, is 
one of the most common, serious congenital musculoskeletal anomalies.  Clubfoot is 
characterized by the inward and rigid downward displacement of one or both feet1.  In 
addition, calf muscles in the affected leg(s) are underdeveloped and remain small even after 
corrective treatment2,3.  The etiology of clubfoot is complex involving both genetic and 
environmental factors.  The genetic variation(s) contributing to this birth defect is largely 
unknown.   Hindlimb and muscle development is a multifaceted well-orchestrated process 
involving cell migration, proliferation, patterning and apoptosis4-9.  These processes are 
tightly regulated by multiple factors such as growth factors, signaling molecules and 
transcription factors4-9.  Dysregulation of genes involved in limb and muscle development 
could contribute to clubfoot.  This chapter reviews hindlimb and muscle development and 
provides a comprehensive discussion of putative etiological mechanisms contributing to the 
etiology of clubfoot.   
1.1 Hindlimb development 
Hindlimb development is an intricate process involving cell proliferation, migration, 
patterning and programmed cell death, all being regulated by multiple factors such as 
growth factors, transcription factors and signaling molecules4-9.  Hindlimb development 
begins during week three of gestation with swelling along the lateral plate mesoderm (LPM) 
initiated by fibroblast growth factor 8 (FGF8) which in turn initiates the expression of 
fibroblast growth factor 10 (FGF10) creating a FGF8-FGF10 positive feedback loop10,11.  In 
addition, T-box transcription factor 4, TBX4, and paired-like homeodomain factor, PITX1, 
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Figure 1.1. Axes of the foot  
 
The three major axes of the foot are 
shown: Anterior-Posterior, Dorsal-
Ventral and Proximal-Distal 
are important for hindlimb induction6-9.  By the 
middle of the fourth week gestation, the limb 
bud is composed of mesenchyme derived from 
the LPM (source of skeletal components) and 
from the myotomes of the paraxial mesoderm 
(source of muscular components).    The 
processes that transform the limb bud to a 
mature limb are commonly defined by three 
major axes:  proximal-distal (PD, running from 
knee to digits), anterior-posterior (AP, running 
from the big toe to the little toe) and dorsal-
ventral (DV, running from the top of the foot to the bottom of the foot)(Figure 1.1).  Three 
key signaling centers are required for proper growth and patterning along the three axes: the 
apical ectodermal ridge (AER), the zone of polarizing activity (ZPA) and the dorsal 
ectoderm10. 
1.1.1 Proximodistal patterning 
Once the limb bud is formed, limb outgrowth is regulated along the proximal-distal 
axis by the AER.  Thickening of the ectoderm at the distal end of the limb bud forms the 
AER containing proliferating, undifferentiated cells expressing four FGFs: FGF4, 8, 9 and 
17 6,12,13.  Currently, three models are proposed to explain proximodistal patterning during 
limb ougrowth10.  The ‘progress zone’ (PZ) model suggests that proximal-distal patterning 
develops progressively, whereby more distal structures are patterned sequentially (Figure 
1.3A)14.  The first mesenchymal cells that leave the PZ will form the more proximal 
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Figure 1.2. Proximodistal Models 
 
A. In the progess zone (PZ) model, initial cells to 
leave the PZ will form the more proximal structures, 
while later cells form the distal structures B. In the 
two-signal model, proximal and distal domains are 
established through RA and FGF and determines 
mesenchymal cell destination. In the early-
specification model, cells are predetermined to form 
the various hindlimb elements (not pictured). 
 
structures, while the later 
mesenchymal cells will form 
distal structures.  The ‘early-
specification model’ proposes that 
cells are predetermined to form 
the stylopod (femur), zeugopod 
(tibia and fibula) and autopod 
(tarsals, metatarsals and 
phalanges)10. The ‘two-signal 
model’ suggests that limb 
mesenchymal cells are initially 
exposed to a proximal signal from 
the lateral mesoderm such as 
retinoic acid (RA) that initiates 
expression of Meis homeobox 
transcription factors which 
influence proximal development 
(Figure 1.2B)15-17.  The AER 
expresses an opposing signal such 
as FGFs to establish a distal domain and these opposing cellular domains form the zeugopod 
of the hindlimb18,19.  
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Figure 1.3. Anteroposterior Models 
 
A. In the classic morphogen model, SHH 
concentration gradient determines A-P limb 
development.  B. In the temporal expansion 
model,  SHH concentration and time determines 
A-P limb development.  In the biphasic model, 
early limb development requires the SHH 
concentration gradient, while later digit 
development only requires SHH as a mitogen (not 
pictured). 
1,2,3,4,5 indicates digit number 
1.1.2 Anteroposterior patterning 
 Anteroposterior patterning is 
regulated by a group of mesodermal 
cells located at the posterior region of 
the limb bud known as the ZPA10.  
Sonic hedgehog (SHH), a morphogen, 
is produced in the ZPA and controls 
number and type of digits.  Posteriorly 
expressed homeobox genes, HOXD10-
13, initiate SHH expression; later in 
limb development these homoebox 
box genes become SHH-
dependent20,21.  Three different models 
have been suggested to explain the 
patterning mechanism along the 
anterior-posterior axis of the 
limb12,22,23.  The classic morphogen 
model suggests SHH creates a posterior-anterior gradient, where cells acquire a positional 
value that changes over time (Figure 1.3A)10,11.  As a consequence of the established SHH 
gradient, GLI3 is expressed10,11. The repressor activity of GLI3 causes a polarizing activity 
with SHH10,11.  The temporal expansion model incorporates SHH exposure time and 
concentration (Figure 1.4B)10,11.  More posterior digital features have longer exposure to 
higher concentrations of SHH, whereas low concentrations of SHH for a shorter period of 
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Figure 1.4. Limb development signaling  
Interaction of the factors that regulate the 
three axes is important for correct limb  
time promote more anterior digital features.  The third model, the biphasic model, proposes 
that digit specification occurs at very early stages of limb development by a SHH 
concentration gradient, while later limb development only requires SHH as a mitogen for 
digit formation10,11. 
1.1.3 Dorsoventral patterning 
Dorsoventral patterning is controlled 
by dorsal and ventral ectoderm derived 
signaling6.   In the dorsal ectoderm, WNT7A 
signals to the dorsal mesenchyme regulating 
a LIM-homeodomain transcription factor, 
LMX1B, to establish dorsal patterning24-26.  
While in the ventral ectoderm, members of 
the BMP family regulate EN1, a homeobox-
containing transcription factor to establish 
ventral patterning27. 
1.1.4 Coordination of the three axes 
 Multifaceted maintenance of each 
individual axis is required for limb formation.  As shown in Figure 1.4, coordination and 
interaction between the three core signaling centers of the three axes allow for correct limb 
morphogenesis.  SHH is required to regulate FGF8 expression and maintenance of FGF4, 9 
and 176.  In turn, FGF4 in the posterior portion of AER and WNT7A in the dorsal ectoderm 
sustain SHH expression in the ZPA10.  SHH positively regulates GREM1, a BMP antagonist 
that blocks BMP inhibitory action on AER-FGF expression10.  BMP signals modulate AER-
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FGF activity by negatively regulating FGF gene expression in the AER.  These precisely 
coordinated interactions allow for accurate hindlimb development and dysregulation of any 
of these key signaling factors could result in a hindlimb malformation. 
1.1.5 Programmed cell death (PCD) 
 Programmed cell death, also called apoptosis, is the process in which unwanted cells 
are actively removed4.  Apoptosis plays an important role in limb development including 
establishment of prechondrogenic condensation, removal of ectoderm along the AER, joint 
formation, establishment of axon pathways and remodeling of the vascular pattern4.   
Apoptosis is involved in the formation of the zeugopod elements, digit formation and 
AER ectoderm, allowing for correct limb shape and skeletal patterning4.  Skeletal formation 
of the tibia and fibula is initiated by apoptosis in the opaque patch (OP), the central 
mesenchyme of the limb bud28.  Massive apoptosis along the interdigital mesoderm known 
as the interdigital necrotic zone (INZ) is needed for digit formation and shape29,30.  In 
addition to apoptosis of mesodermal cells, cell death occurs along the ectoderm of the AER 
and inhibition or delay of apoptosis in the AER results in polydactyly31. 
 Common mechanisms and pathways known to regulate proliferation and 
differentiation are involved in programmed cell death.  BMPs, bone morphogentic proteins, 
in particular BMP2, 4 and 7, are known to trigger apoptosis in both mesodermal cells and in 
the AER ectoderm5.  In addition, BMPs are involved in chondrogenic differentiation 
mediated through the BMP type Ib receptor, while initiation of activated BMP apoptosis 
remains unknown4,32,33.  Multiple pathways have been identified which regulate BMP-
initiated apoptosis.  For example, BMP activation can be initiated through SMAD1, SMAD5 
and SMAD8; however, SMAD1 and SMAD8 are only expressed in the interdigital tissue10.  
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Phosphorylated SMAD levels coincide with the onset of programmed cell death, thus cell 
death in the INZ may be mediated through BMP-SMAD signaling4.  Conversely, BMP 
activation can initiate a protective response through FGF signaling in interdigital 
mesenchyme10.  Decreases in FGF8 correlate with premature cell death via BMP 
signaling10.  However, inactivation of BMP signaling leads to increased expression of FGF8 
in the AER10.  Multiple factors are also known to regulate BMP-signaling that modulate 
intensity and/or spatial distribution.  For example, GREM1, a BMP antagonist, expresses in 
a pattern to protect undifferentiated mesoderm from apoptosis4. 
 In addition to BMP-regulated apoptosis, RA is involved in regulating apoptosis10.  
RA, a derivative of retinol (vitamin A) metabolism, is mediated by two types of nuclear 
receptors, RAR and RXR34,35.  RA induced apoptosis is mediated by BMPs36.  In contrast, 
inhibition of RA leads to the failure of interdigital cell death36.  Thus, RA most likely 
activates the cascade that leads to interdigital cell death.  
 Final processing of programmed cell death involves the activation of executioner 
caspases through two main pathways, intrinsic and extrinsic (Figure 1.5)10.  The extrinsic 
pathway is activated by death receptors such as FADD, Fas-associated via death domain37,38.  
With the activation of death receptors, CFLAR, an apoptotic antagonist, isreleased, causing 
an activation of caspase 8 (CASP8) and 10 (CASP10)39.  CASP8 or 10 then initiates the 
release of cytochrome c from the mitochondria39.  In the intrinsic pathway, the release of 
cytochrome c is initiated by pro-apoptotic proteins, BAX, BAK and BID4.  Once 
cytochrome c is released from the mitochondria, the intrinsic and extrinsic pathways are 
congruent.  Cytochrome c interacts with APAF1, activating CASP9 which, in turn, activates 
the executioner caspases such as CASP3 to carry out the final stages of cell death40. 
 Figure 1.5. Intrinsic and extrinsic programmed cell death pathway
 
The extrinsic pathway is activated by death receptors causing a cascade of events 
beginning with the activation of 
from the mitochondria.  The extrinsic and intrinsic pathway converge with the release of 
cytochrome c leading to the final activation of 
cell death. 
1.2 Hindlimb muscle development
 All body muscle, except for head musculature, is derived from the condensation of 
paraxial mesoderm into epithelial structures called somites, epithelial balls of cells.  The 
dorso-lateral region of the somite forms the dermomyotome which will give rise to
and muscle progenitors cells (MPC)
 
CASP8 and CASP10 and in turn releasing cytochrome c 
CASP3 carrying out the final stages of 
 
41
. The hypaxial (dorso-lateral lip) part of the 
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 dermis 
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dermomytome generates the limb, tongue, diaphragm and ventral wall musculature41.  
Beginning at embryonic day 11.0 (E11), thousands of muscle progenitors cells originating 
from the hypaxial part of the dermomytome migrate to the hindlimb bud41.  Migration of 
these progenitor cells are regulated by PAX3 and LBX1, both homeobox transcription 
factors42,43.  At this stage, the cells are undifferentiated muscle cells also known as 
myoblasts (mononucleated).  Initially, as the myoblasts enter the limb bud, they begin to 
form dorsal and ventral muscle masses, largely dependent upon scatter factor/hepatocyte 
growth factor (SF/HGF) expressed in the limb mesenchyme44,45.  Once in the actual limb 
bud,  multiple factors such as BMPs, WNTs, FGFs, SHH, RA and apoptosis further refine 
and position these premuscle masses46.  Myogenic differentiation, the formation of skeletal 
muscle cells also known as myotubes, begins with the expression of myogenic regulatory 
transcription factors (MRFs)41,47,48.  MYF5 (myogenic factor 5) and MYOD1 (myogenic 
differentiation 1) are the first factors to designate myogenic commitment, followed by 
MRF4 and MYOG (myogenin)41,47. 
 Terminal differentiation requires the formation of highly specific and well-organized 
slow and fast muscle fiber types.  Primarily, the hindlimb is composed of slow- and fast-
twitch muscle fibers characterized by the expression of specific myosin heavy chains 
(MYH) and distinct metabolic activities.  Fast-twitch muscle fibers are characterized by 
quick, force generating contractions that fatigue easily41.  Slow-twitch muscle fibers use 
oxidative metabolism to generate slower, longer contractions41.  Specification of when and 
where myogenic cells form slow- or fast-twitch muscle fibers has been an ongoing debate.  
One model suggests that limb myogenic cells are predisposed to either a slow or fast 
fate41,49-53.  Studies have shown that the first premyogenic cells to enter the limb bud form 
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Figure 1.6. Clubfoot 
Clubfoot is characterized by forefoot 
adduction (1), midfoot cavus (2) and 
hindfoot varus and equinus (3). 
 
Adapted from www.fpnotebook.com with permission 
the proximal slow-twitch muscles, while the second migratory wave of cells form the fast-
twitch muscles54.  Other studies, however, propose a model that premyogenic cells are 
unspecified and have the ability to generate slow- or fast-twitch muscle fibers and formation 
of either fiber is influenced by limb bud factors55-58.  A combination of these two models has 
also been suggested, where the myogenic cells are initially biased towards a slow or fast 
fate, however once in the limb bud, factors within the limb bud overrule this bias towards a 
fiber fate specified by the local limb bud factors49,59.   
1.3 Clubfoot 
 Clubfoot (congenital talipes equinovarus, CTEV) is one of the most common birth 
defects involving the musculoskeletal system.  Positional deformation of the foot responds 
to minimum manipulation and therefore is not considered to be clubfoot60.  A true clubfoot 
is a rigid malformation.  While there is no universally accepted clubfoot classification 
scheme, two classification systems, one 
developed by Dimeglio et al. and the other by 
Pirani et al. are most commonly used61,62.  
Both systems apply a point score (0-20) based 
on a number of different physical findings, 
which when totaled is used to predict clubfoot 
severity with the higher score equaling 
greater severity.  As shown in Figure 1.6, 
clubfoot consists of four components: equinus 
(downward), hindfoot varus (inward), 
forefoot adductus (inward) and cavus (high 
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arch)1.  Clubfoot mimics the embryonic foot position during the second month of embryonic 
development.  In addition, to structural malformation of the foot, individuals with clubfoot 
have persistent calf muscle hypoplasia. 
1.3.1 Isolated (nonsyndromic) clubfoot 
 Twenty to twenty-five percent of clubfoot cases are associated with a syndrome such 
as distal arthrogryposis (DA), congenital myotonic dystrophy, myelomeningocele, amniotic 
band sequence, Trisomy 18 and Chromosome 22q11 deletion63-65.  The remaining 75-80% 
of cases are isolated (idiopathic, no other malformations).  Isolated clubfoot is a common 
birth defect, although the birth prevalence varies across ethnicities with a high of 1/150 in 
Polynesians, a low of 1/2500 in African Americans and a worldwide average rate of 
approximately 1/1000 live births66-71.  Half of all cases have both feet affected (bilateral), 
while those unilateral cases involve the right foot being affected more often than the left69,72.  
Males are affected twice as often as females72,73.    
1.4 Treatment 
 Untreated clubfoot results in a rigid deformity causing gait disturbance, callus 
formation and skin/bone infections.  This leads to substantial limitations in mobility and 
employment opportunities, particularly in third world countries.  Fortunately, multiple 
treatment options are available.  Early treatment methods relied heavily on surgery as the 
first choice in corrective treatment for clubfoot74,75.  One of two surgical methods were 
typically used, the ‘a la carte’ or ‘one-size fits all’.    In 1979, Turco described the ‘one-size 
fits all’ approach as each foot undergoing the same surgical procedure74.  In 1987, the ‘a la 
carte’ approach described by Bensahel et al. involved the release of all structures until full 
correction of the foot was obtained75.  Because of often observed side effects after surgical 
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treatment such as persistent painful feet, residual deformities and relapses, more 
conservative approaches were developed.  The two most common nonsurgical methods now 
used are Ponseti and Montpellier (French or functional), both promoting the progressive 
stretching of the muscles and tendons to avoid the use of a surgical soft tissue release 
procedure76,77.  For both methods, treatment beginning within the first few weeks of life is 
ideal.   The Ponseti method involves serial manipulation, casting and bracing, along with 
cutting of the Achilles tendon (when necessary) to obtain a corrective foot75,77-79.  In contrast 
the Montpellier method involves daily manipulations of the clubfoot and uses adhesive 
taping to maintain the correction achieved with stretching75,79.  The Montpellier method 
requires more parental participation but allows more flexibility in the foot, whereas the 
Ponseti method is less time consuming but more restrictive with foot movement because of 
the casting and bracing.  However, while conservative treatment methods have improved 
outcomes, they do not always work and surgery is needed to correct the foot to normal 
plantar position.  Even after correction, the calf muscle of the affected leg(s) remains 
underdeveloped. 
1.5 Clubfoot etiology 
Clubfoot is a complex birth defect that does not follow a classic Mendelian 
inheritance pattern.  Studies suggest a multifactorial model with both genetic and 
environmental factors, separately and in combination, contributing to the etiology of 
clubfoot.  In addition, multiple theories have been suggested as causes for clubfoot and will 
be discussed in the following sections. 
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1.5.1 Etiologic theories for clubfoot 
As early as 400 BC, Hippocrates described the first clubfoot and he believed that the 
pressure from uterine molding on the developing foot caused deformity80.  The restriction of 
fetal foot movement by the uterus as a cause for clubfoot became a widely held hypothesis81-
83
.  Multiple births, reduced amniotic fluid volume, prolonged gestation, younger maternal 
age and increased birth weight have also been suggested to cause decreased fetal 
movement82,84,85.  Amniotic leakage due to early amniocentesis has been associated with 
clubfoot, which would further suggest decreased fetal movement as a cause for clubfoot84.  
However, multiple studies have shown no association with lack of fetal movement as a 
cause for clubfoot69,86-89  In addition, clubfoot is detected by ultrasound early in the second 
trimester, which is well before uterine constraint would affect the developing fetus.  
Furthermore, Wynne-Davies found concordance for clubfoot was the same between 
dizygotic twins and single births providing evidence against decreased limb movement as a 
cause for clubfoot89.  Other mechanisms including bone, connective tissue, vascular and 
neurological abnormalities have been suggested; none have been proven82,84,89-94.   
The developmental arrest theory suggested by Hueter and von Volkmann has 
become more widely accepted1.  Beginning at the second month of development the hind-
foot resembles a clubfoot that normally rotates out to the normal plantar grade position95.  
However, developmental arrest at this critical time point (weeks 9-11) could result in a 
clubfoot1,96. 
1.5.2 Environmental causes of clubfoot 
 Environmental factors have been suggested to contribute to clubfoot.  Seasonal 
variation has been observed in some studies with higher birth prevalence incidence in winter 
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(December-March), while other studies have found no correlation85,97-100.  Teratogen 
exposure such as sulfonamides and abortifacient agents has been suggested but no solid 
epidemiological evidence supports these assertions37,38.  While maternal folic acid 
supplementation has shown a decrease in birth prevalence of neural tube defects, only a 
small reduction in isolated clubfoot has been found on a population basis40,71.    
Only maternal smoking is consistently associated with clubfoot.  Mothers who 
smoke during pregnancy have an increased risk of having a child with clubfoot and this risk 
increases in a dose-dependent pattern (Relative Risk: 1.3 to 2.2)93,101,102.  Maternal smoking 
during pregnancy and a positive family history of clubfoot increases the risk of clubfoot 20-
fold101.   
1.5.3 Genetic causes of clubfoot 
 Evidence for a genetic etiology for clubfoot comes from studies showing (1) 
aggregation of clubfoot in families, (2) increased risk with number of affected siblings, (3) 
heritability for clubfoot of 72% and (4) higher concordance in monozygotic twins than 
dizygotic twins (32.5% vs. 2.9%)88,103-105.  Segregation analyses of various populations 
support a multifactorial/oligogenic model67,71,81,89,103,106,107.  This model also accounts for 
gender differences observed in multiple population studies108.  Males are affected more often 
than females, thus females require more susceptibility loci than males108.  This is known as 
the Carter effect and is part of the multifactorial model108.  It is now well accepted that 
genetic variation contributes to clubfoot, however the mechanism(s) are not well understood. 
1.6 Approaches to candidate gene identification 
Given that there is a genetic component to clubfoot, studies have focused on 
identifying the genes64,69,71,73,104,109,110.  Currently, there are many approaches to identify 
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candidate genes for clubfoot such as genome-wide scans, animal models, syndromes, 
developmental pathways and chromosomal abnormalities.  A gene is identified as a potential 
candidate for clubfoot because of its biological relevance; typically the gene plays a role in 
hindlimb development.  Once a candidate gene is identified, polymorphisms such as single 
nucleotide polymorphisms (SNPs) and short tandem repeats (STRs) that span the gene of 
interest are identified and genotyped within an affected population.  There are various 
analytic methodologies to test for association and/or linkage depending on study design.  
Linkage analysis utilizes the tendency for certain alleles to be inherited together even after 
recombination and are typically performed on families with multiple affected individuals111.  
Association studies test whether the sequence variant has a frequency in an affected 
population significantly different from the frequency in the general population111.  
Association studies work well with case-control studies, but can also be performed on 
datasets composed of families and trios111.  The following sections will discuss the genetic 
variants identified through these approaches that contribute to the genetic etiology of 
clubfoot. 
1.6.1 Genome scans 
 Genome-wide scans utilize polymorphic markers such as SNPs and copy number 
variants (CNVs) that span the whole genome to identify linked and/or associated regions 
with a phenotype of interest.  Currently, only one genome-wide linkage scan has been 
reported on one five generation clubfoot family incorporating 13 family members112.  
Linkage to chromosome 5q31 with a LOD score of 3.3 was found.  PITX1, a transcription 
factor that is required for hindlimb expression, is located within this region.  A single 
missense mutation (E310K) in PITX1 segregated with clubfoot and was not present in 500 
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controls112.  Many of the affected individuals with the mutation had other skeletal 
malformations in addition to clubfoot indicating that the affected individuals did not have 
isolated clubfoot112.  Interestingly, a genome-wide CNV array on forty clubfoot probands 
identified one individual with a 241 kb chromosome 5q31 microdeletion involving 
PITX1113.  The deletion segregated in an autosomal dominant pattern over three 
generations113.  In addition, a recent study reported haploinsufficiency of Pitx1 in mice 
having a clubfoot-like phenotype with 8.9% penetrance (20 out of 225 mice)113.  The 
haploinsufficient Pitx1 mouse slightly differs from human clubfoot in some phenotypic 
characteristics such as females being affected more often than males, peroneal artery 
hypoplasia and reduced tibial and fibular bone volumes.  These findings suggest that the 
E310K PITX1 mutation plays a role in syndromic clubfoot, while PITX1 haploinsufficiency 
contributes to isolated clubfoot. 
 A 17q23.1q23.2 microduplication in three families with clubfoot segregating in an 
autosomal dominant pattern with reduced penetrance was identified in the genome-wide 
CNV array114.  The 17q23.1q23.2 microduplication contains the T-box transcription factor 4, 
TBX4, which is specifically expressed in the hindlimb and is important for muscle 
patterning115,116.  TBX4 is a direct transcriptional target of PITX1117.  The authors suggest 
that the 17q23.1q23.2 microduplication is a common cause for familial isolated clubfoot and 
that the TBX4-PITX1 pathway could play a role in isolated clubfoot.  However, the three 
individuals identified to have the microduplication also had other skeletal malformations 
such as short wide feet and toes suggesting variable expressivity. Studies performed in Dr. 
Jacqueline T. Hecht’s laboratory (Hecht lab) identified only one multiplex family with this 
microduplication118.  This microduplication segregated in a large multigeneration family 
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with clubfoot and short, wide feet, once again supporting variable expressivity with this 
microduplication118.  Interestingly, no association was found for TBX4 and clubfoot118.  
Thus, the role of TBX4 in the etiology of isolated clubfoot is still being investigated. 
1.6.2 Developmental genes 
 Hindlimb and muscle development involves the interaction of multiple pathways 
involving growth factors, transcription factors, receptors and many other factors (Section 
1.1).  Limb initiation, patterning, outgrowth and development are all required for correct 
limb formation, in which perturbation of any of these genes could contribute to a clubfoot.  
Thus, there are many potential candidate genes for clubfoot in these developmental 
processes. 
1.6.3 Chromosomal abnormalities 
 Chromosomal deletions, duplications and translocations that cause syndromes with 
multiple malformations have been shown to harbor genes that contribute to isolated birth 
defects.  One of the first studies to identify chromosomal abnormalities associated with 
syndromic clubfoot was reported by Brewer et al65,119.  This study compiled individuals who 
had a variety of phenotypic characteristics caused by chromosomal deletions and 
duplications.  Phenotypic abnormalities were listed by specific diagnosis and chromosomal 
detections.   For clubfoot, this included six large chromosomal deletion regions on 2q31-33, 
3q23-24, 4p16-14, 7p22, 13q33-34 and 18q22-23 and two duplication regions on 6q21-27 
and 10p15-1165,119.  Our lab (the Hecht lab) systematically interrogated each region for 
genes associated with clubfoot120,121.  Beginning with the 2q31-33 deletion region, two short 
tandem repeats (STRs), GATA149B10 and D2S1371, were found to be associated with 
clubfoot120.  GATA149B10 was located near three apoptotic genes, CASP8, CASP10 and 
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CFLAR.  These genes are involved in the mitochondrial-mediated apoptotic pathway which 
is consistent with the key role that apoptosis plays in limb and muscle development (see 
Sections 1.1.5 and 1.2).  Interrogation of the seven genes (CASP9, CASP10, CASP8, CASP3, 
APAF1, BCL2 and BID) involved in this pathway identified suggestive associations with a 
SNP in each gene and clubfoot121.  Further analysis of the 2q31-33 deletion identified 
another candidate gene, Homeobox gene cluster D (HOXD).  The HOXD gene cluster directs 
limb and muscle patterning during development and is functionally redundant with the 
Homeobox A gene cluster (HOXA) located on chromosome 7p15122-124.  Mutations in both 
HOXA and HOXD have been associated with syndromes that involve limb abnormalities but 
not clubfoot125,126.  Interrogation of these genes in our clubfoot nonHispanic white (NHW) 
and Hispanic multiplex and simplex families discovery group found associations with SNPs 
in both gene clusters and clubfoot127.  One SNP, rs3801776, located in the basal promoter of 
HOXA9, gave the strongest association with clubfoot in both discovery and validation 
clubfoot groups127.  These results suggest that perturbation in genes involved in limb and 
muscle development play a role in clubfoot. 
1.6.4 Animal models of clubfoot 
 Animal models have proven to be useful tools in identifying candidate genes for 
many different diseases and birth defects128,129.   Several mechanisms have been used to 
create animal models that harbor a phenotype of interest.  Suggestive clubfoot-like animal 
models have been generated, but many show differences from human clubfoot.  RA, a 
teratogen previously discussed in section 1.1.5 has been used in mice and rats to induce a 
clubfoot-like phenotype130-132.  High levels of RA can lead to birth defects, while lack of RA 
can prevent normal embryonic development28.  These studies utilizing RA administered 
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above normal levels, thus creating an unnatural environment for the pregnant mother, thus 
suggesting a nonviable clubfoot animal model.    Some studies have suggested early 
amniocentesis as a cause for some sporadic cases84,133.  A study performing amniotic sac 
punctures in mice observed a clubfoot phenotype133.  However, the amniotic sac puncture 
animal model had multiple malformations thus causing a syndromic form of clubfoot and 
not isolated clubfoot.  One other mouse model is the pma mutant mouse, which lacks the 
peroneal nerve134-136.  This mouse model closely recapitulates the human form of clubfoot 
however the peroneal nerve is present and usually normal in most cases of human 
clubfoot136-138.    Currently, the only plausible clubfoot model is the PITX1 haploinsufficient 
mouse discussed in section 1.6.1.  Though the haploinsufficient Pitx1 mouse differs slightly 
in phenotypic characteristics compared to the human form, this genetic model of clubfoot 
may provide important clues about the genetic underpinnings of clubfoot. 
1.6.5 Syndromes 
 Clubfoot can occur as a phenotypic manifestation of a syndrome that follows a 
Mendelian mode of inheritance and has a known genetic cause.  It has been hypothesized 
that gene mutations causing syndromic clubfoot may harbor variants (common or rare) that 
contribute to isolated clubfoot.  Distal Arthrogyrposis (DA) is a syndrome characterized by 
congenital joint contractures including clubfoot139.  Currently, there are nine different types 
of DA and clubfoot occurs in four types.  Mutations in muscle contraction genes, MYH3, 
TNNT3, TNNI2, TPM2, MYBPC1 and TPM8, cause DA1, DA2A, DA2B and DA7139-148.  
Coding exons of MYH3, TNNT3 and TPM2 from 20 clubfoot probands were sequenced in a 
recent study149.  Rare variants were identified but none segregated with the disease 
phenotype.  The authors concluded that these genes do not contribute to the genetic etiology 
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of clubfoot149.  Since the promoter regions of these genes were not assed, these genes remain 
candidates for clubfoot and studies focusing on these genes are presented in Chapter 5. 
1.7 Significance 
 Clubfoot is a common birth defect affecting 135,000 newborns annually worldwide.  
Even with corrective treatment, foot and leg abnormalities and discomfort often persist.  The 
complex genetic heterogeneity underlying clubfoot has only recently been appreciated and 
needs to be further investigated.  Identification of these genetic factors will aide in 
identifying at-risk genotypes and this information may be translated into better clinical care 
and genetic counseling.  
The goal of this project was to identify genetic variants that contribute to clubfoot in 
our well-characterized NHW and Hispanic multiplex and simplex clubfoot families.  
Interrogation of candidate genes from an animal model and a genome-wide linkage scan are 
discussed in Chapters 3 and 4.  Muscle contraction genes implicated to cause syndromic 
clubfoot are assessed in Chapter 5.  Functional implications of associated regulatory SNPs in 
TPM1, TPM2, TNNC2 and HOXA9 are described in Chapter 6.  Overall, this project utilized 
multiple approaches and identified regulatory SNPs associated with clubfoot suggesting a 
common mechanism, gene regulation, as playing a key role in the genetic etiology of 
clubfoot.   
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A. Multiplex 
 
 
B. Simplex 
 
Figure 2.1. Multiplex and simplex 
family structures 
Figure represents structure of 
multiplex (A) and simplex families 
(B).  Circles represent females and 
squares represent males.  Solid 
shapes indicate affected status. 
2.1 Dataset 
 Institutional review board (IRB) approval 
for the use of these human samples was obtained 
from the Committee for the Protection of Human 
Subjects at the University of Texas Health 
Sciences Center at Houston (HSC-MS-04-239).  
Clubfoot families were recruited from clinics at 
Shriners Hospitals for Children in Houston, Los 
Angeles and Shreveport, and Texas Scottish Rite 
Hospital for Children of Dallas and the University 
of British Columbia.  All probands and family 
members underwent clinical and radiographic 
examinations to exclude syndromic cases of 
clubfoot.  Ethnicity was self-reported.  Two 
generation pedigrees were obtained for all probands and expanded based on a positive 
family history.  Pedigrees were subdivided into simplex trios (those without affected 
relatives = no family history) and multiplex families (those with multiple affected 
individuals = family history) (Figure 2.1).  Our primary (discovery) dataset was comprised 
of 600 clubfoot families (1,923 individuals).  Clinical information about the discovery 
dataset is listed in Table 2.1. 
 After informed consent was obtained, blood and/or saliva samples were collected 
from patients and family members.  In the presence of a family history, all family members’ 
saliva were collected either in person or mail.  DNA was extracted from blood using the 
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Table 2.1.  Clubfoot Discovery Dataset 
NHW Hispanics Total 
+FH -FH Total +FH -FH Total +FH -FH Total 
Families 149 144 293 91 216 307 240 360 600 
Individuals 400 637 1037 326 560 886 726 1197 1923 
Male 334 204 538 156 279 435 490 483 973 
Affected 186 98 284 83 152 235 269 250 519 
Sidedness                   
Left side 28 18 46 17 38 55 45 56 101 
Right side 29 23 52 15 35 50 44 58 102 
Unilateral* 4 0 4 0 0 0 4 0 4 
Bilateral 109 56 165 49 77 126 158 133 291 
CF Unknown 16 1 17 2 2 4 18 3 21 
Female 303 196 499 170 281 451 473 477 950 
Affected 90 46 136 45 64 109 135 110 245 
Sidedness                   
Left side 13 12 25 7 18 25 20 30 50 
Right side 13 11 24 8 18 26 21 29 50 
Unilateral* 3 0 3 0 0 0 3 0 3 
Bilateral 56 23 79 26 28 54 82 51 133 
CF Unknown 5 0 5 4 0 4 9 0 9 
*CF side not known 
FH: Family History 
 
Roche DNA Isolation Kit for Mammalian Blood (Roche, Switzerland) and from saliva using 
the Oragene Purifier for Saliva (DNA Genotek, Inc., Ontario, Canada) following 
manufacturer’s protocol.  DNA samples were quantified using the Nanodrop 
spectrophotometer (Thermo Fisher Scientific, Waltham, MA) and checked for degradation 
on 2% agarose gels.  DNA was stored at -20°C. 
 A secondary (validation) dataset was ascertained and characterized in the Orthopedic 
Clinic in the Department of Orthopedics at Washington University in St. Louis, MO.  The 
validation dataset consisted of 142 NHW simplex trios.  The validation dataset was used to 
confirm positive results in the discovery dataset. 
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 A case-control validation dataset was composed of DNA from de-identified isolated 
clubfoot cases and matched control newborn blood spots from the Texas Birth Registry.  
Controls were matched to the cases by sex, maternal ethnicity, county of maternal residence, 
and birth ±8 weeks of the case’s date of birth.  This case-control dataset consisted of 616 
NHW (308 cases and 308 controls) and 752 Hispanics (376 cases and 376 controls).  DNA 
was extracted from the dried blood spots using the Qiagen DNeasy blood and tissue kit 
(Qiagen, Valencia, CA) and amplified using the Qiagen REPLI-g kit (Qiagen,Valencia, CA) 
following the manufacturer’s protocol. 
2.2 SNP selection and genotyping 
 Single nucleotide polymorphisms (SNPs) were identified using the National Center 
for Bioinformatics (NCBI, http://www.ncbi.nlm.nih.gov) and HapMap (www.hapmap.org) 
websites.  SNPs were chosen based on (1) heterozygosity greater than or equal to 0.3 in 
NHW population (HapMap CEU dataset), (2) minor allele frequency greater than 0.2 in 
NHW population, (3) exonic and coding SNPs given higher priority over intronic SNPs, (4) 
“tagging” ability of SNPs, which provide genotyping information for multiple SNPs in 
linkage disequilibrium and (5) coverage of the gene 1 SNP every 10 kilobases on average 
including upstream and downstream of the gene.  “Tagging” SNPs were identified using 
Haploview150.  Genotyping was performed using either TaqMan® SNP Genotyping Assays 
or SNPlexTM (Applied Biosystems, Foster City, CA).  TaqMan® results were analyzed on 
the 7900HT using SDS 2.1 (Applied Biosystems, Foster City, CA).  SNPlexTM results were 
analyzed on a 3730 using GeneMapper® 4.0 (Applied Biosystems, Foster City, CA).  
Manufacturer’s protocols were used to perform both genotyping assays.  Genotype calls 
were imported into Progeny Lab database management software (Progeny Software, Delray 
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Beach, FL).  PedCheck software was used to check for Mendelian inconsistencies and 
discrepancies151. 
2.3 Statistical Analyses 
 Analyses were performed on the dataset as a whole (all) and then stratified based on 
the presence (multiplex) or absence (simplex) of family history.  Allele frequency and 
Hardy-Weinberg equilibrium (HWE) was calculated by SAS (Statistical Analysis Software) 
v9.1.  For the majority of SNPs, the allele frequency significantly differed (p<0.05) between 
NHW and Hispanics, thus analyses were performed on each ethnicity separately for all tests.  
GOLD (Graphical Overview of Linkage Disequilibrium) was used to calculate pairwise 
linkage disequilibrium (LD) and displayed using Haploview150,152. 
 Multiple methods to assess linkage and/or association were used to obtain the 
maximum amount of information from our datasets.  Parametric and non-parametric linkage 
analyses were conducted using Merlin (Multipoint Engine for Rapid Likelihood 
Inferences)153.  Two parametric models based on segregation analysis were tested on the 
multiplex families107,109,154.  Model I used penetrances of 0.000, 0.020, 0.494 and 0.0, 0.008, 
0.358 while model II used 0.0, 0.002, 0.067 and 0.0, 0.008, 0.358 for males and females, 
respectively. 
 Single SNP association with clubfoot was tested using three different analyses: PDT 
(pedigree disequilibrium test), geno-PDT (genotype PDT) and APL (association in the 
presence of linkage).  PDT utilizes the traditional transmission disequilibrium test (TDT) 
while incorporating extended family members in addition to the nuclear family155.  The 
geno-PDT is an expansion of PDT that focuses on the association of a genotype and clubfoot 
and is more accurate when looking at dominant and recessive models156.  APL allows for the 
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incorporation of families in which a parental genotype is missing157.  In addition to single 
SNP analysis, 2-SNP haplotype association was analyzed using APL157.  Generalized 
estimating equations (GEE) was used to detect gene-gene interaction; assessing whether 
SNPs in two different genes is associated with clubfoot158.   
2.4 In silico analysis to assess transcription factor binding 
 In silico analyses were performed to assess potential function of associated 
regulatory SNPs (p<0.05).  Using three online binding site prediction programs, Alibaba2, 
Patch and TESS, these programs predict whether the ancestral or alternate allele creates, 
eliminates and/or alters transcription factor binding159-161.  The ancestral allele is defined by 
NCBI as the allele originating from the chimpanzee genome.  Sequences for the ancestral 
and alternate allele were obtained from NCBI (www.ncbi.nlm.nih.gov) and inputted into the 
three online programs.  Predicted outputs were compared across all three programs. 
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CHAPTER 3: Variation in IGFBP3 
contributes to clubfoot 
 
 
 
 
 
 
 
Note: The information presented in this chapter was published in 2009, in which I was co-
first author: “Altered transmission of HOX and apoptotic SNPs identify a potential common 
pathway for clubfoot.”  Am J Med Genet A 149A(12), 2745-52 (2009).  Permission for use 
of the article in this dissertation has been obtained from the American Journal of Medical 
Genetics Part A. 
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3.1  Introduction 
 The candidate gene approach has been successful in gene discovery in human 
genetics and has provided valuable information on the genetic etiology of clubfoot (see 
discussion in Section 1.6).  Various approaches have been utilized to identify potential 
candidate genes for clubfoot.  One approach utilizes chromosomal abnormalities such as 
duplications and deletions that cause syndromic clubfoot.  Brewer et al. identified six 
chromosomal deletion regions and two duplication regions specific for syndromic 
clubfoot65,119.  Evaluation of these chromosomal regions identified the HOXD gene cluster in 
the 2q31-q33 deletion region as biologically relevant transcription factor genes for isolated 
clubfoot because they direct limb and muscle patterning and differentiation 122,123.  In 
addition, the HOXA gene cluster located on 7p15-p14 has a redundant function with 
HOXD122,123.  Mutations in the HOXA and HOXD gene clusters cause limb abnormalities 
including synpolydactyly and brachydactyly21,125,126,162-165.  HOXA and D genes are 
important because they are spatially and temporally regulated during embryogenesis and 
specify limb patterning122,123.  Twenty SNPs spanning the HOXA and HOXD genes were 
interrogated in our clubfoot discovery dataset.  Strong association was found for one SNP, 
rs3801776, located in the regulatory region of HOXA9, in both our discovery and validation 
datasets127.  In addition, multiple gene interactions between the HOXA and D clusters and 
the mitochondrial-mediated apoptotic genes were associated with clubfoot127.  These results 
suggested that perturbation of the HOXA and D gene clusters and apoptotic genes may play 
a role in clubfoot. 
 Interestingly, conditional knockout of Hoxa13 in mice causes loss of digits and 
decreased apoptosis166.  These mice show decreased expression of insulin-like growth factor 
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binding protein (IGFBP3) in their hind limbs.  IGFBP3 belongs to a family of six genes that 
are involved in modulating insulin-like growth factors (IGFs), which regulate cell 
proliferation and apoptosis167-169.  Previous studies performed in our lab identified 
associations with mitochondrial-mediated apoptotic genes and clubfoot (see Section 
1.6.2)121.  Furthermore, subcutaneous injections of the IGF-I/IGFBP3 protein complex slows 
the onset of muscle atrophy in immobilized hind limbs of rats, which is relevant because 
individuals with clubfoot show calf muscle hypoplasia170.  The involvement of IGFBP3 in 
multiple processes of limb development such as apoptosis and muscle formation suggest that 
IGFBP3 is a biologically important candidate gene for clubfoot121.  Thus, IGFBP3 was 
interrogated in our clu 
3.2  Materials and Methods 
 Information pertaining to our clubfoot discovery and validation datasets, sample 
collection, DNA extraction, SNP selection, genotyping and analysis (PDT, geno-PDT, APL, 
GEE and transcription factor binding) are described in Chapter 2. 
  For this analysis, 598 families including 179 multiplex (122 NHW and 57 
Hispanic) and 331 simplex (130 NHW and 201 Hispanic) families from the discovery 
dataset and 142 NHW trios in the validation dataset were used.  Twelve IGFBP3 SNPs were 
genotyped in our discovery dataset (Table 3.1).   
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3.3 Results 
 All SNPs were in HWE except for rs10255707 which was removed from further 
analysis.  Parametric and nonparametric multipoint linkage analysis detected suggestive 
evidence (maximum LOD>1.5) in the Hispanic discovery dataset (Table 3.2).  
 The strongest association was with rs13223993, located downstream of IGFBP3.  
This SNP was significantly associated with all three statistical tests in the NHW simplex 
discovery dataset (Table 3.3).  The remaining associations were marginal for both single 
SNP and 2-SNP haplotype associations in the discovery and the validation dataset.  No 
single SNP association was found in the Hispanic discovery dataset (data not shown).  
However, it is of interest that many of these marginal associations involve SNPs located in 
Table 3.1. IGFBP3 SNPs 
dbSNP Chr:bpa Location Allelesb MAF HMAFc 
rs2132571 7:45928199 U A/G 0.306 0.218 
rs2132572 7:45928070 U A/G 0.227 0.478 
rs2854744 7:45927600 U A/C 0.472 0.316 
rs2854746 7:45927170 E1 (missense) C/G 0.415 0.264 
rs2854747 7:45926442 I1 C/T 0.415 0.631 
rs3793345 7:45924203 I1 C/T 0.199 0.15 
rs2471551 7:45923580 I1 C/G 0.192 0.154 
rs3110697 7:45921554 I3 A/G 0.422 0.629 
rs10255707 7:45921217 I3 C/T 0.244 0.545 
rs2453839 7:45920098 I4 C/T 0.197 0.13 
rs6670 7:45918779 3' UTR A/T 0.216 0.129 
rs13223993 7:45917755 D A/G 0.248 0.289 
MAF: minor allele frequency; HMAF: Hispanic minor allele frequency; 
U: upstream; I: intron; E: exon; UTR: untranslated region; D: downstream 
aSNP data source; NCBI map – genome build 36.3 
bMajor allele listed first based on NCBI CEU listing 
cHispanic corresponding minor allele frequency 
Cited with permission from Am J Med Genet A, Ester, Weymouth et al., 
2009 
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Table 3.2. IGFBP3 multipoint linkage results for 
Hispanics 
Nonparametric Parametric 
dbSNP LOD p-value HLODa 
rs2132571 2.06 0.001 1.93 
rs2854746 2.13 0.0009 2.01 
rs2453839 2.22 0.0007 2.12 
rs6670 2.29 0.0006 2.19 
rs13223993 2.29 0.0006 2.19 
aAll families linked under Modell II 
(See Section 2.3 for model design) 
Cited with permission from Am J Med Genet A, Ester, 
Weymouth et al., 2009 
 
potential regulatory regions (Table 3.3 and 3.4).  One of these SNPs, rs2132571, located in a 
potential regulatory region, was confirmed in our validation dataset (p=0.04).  
 Because of decreased IGFBP3 expression in the conditional HOXA13 knockout 
mouse and its role in apoptosis, potential gene interactions between IGFBP3 and the HOXA 
and D genes and the mitochondrial-mediated pathway genes were evaluated. Interactions 
were found (p<0.05) in both the NHW and Hispanic discovery datasets (Tables 3.5 and 3.6, 
p<0.01 only shown).  The most significant interactions in the NHW dataset were between 
rs3801776/HOXA9, a promoter SNP, and rs13223993/IGFBP3, located downstream 
(p=0.0001), and rs2132572/IGFBP3, a potential regulatory SNP and rs1049210/CASP3, a 
missense mutation.  The most significant interactions in the Hispanics were 
rs13223993/IGFBP3 and rs741610/HOXD (p=0.002) and rs2453839/IGFBP3 and 
rs2278361/APAF1 (p=0.002). 
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Table 3.3. Single SNP Associations in NHW* 
 
ALL Multiplex Simplex 
dbSNP PDT 
geno-
PDT APL PDT 
geno-
PDT APL PDT 
geno-
PDT APL 
rs2132571 0.206 0.378 0.100 0.365 0.691 0.086 0.362 0.360 0.605 
rs2132572 0.105 0.217 0.154 0.571 0.570 0.860 0.027 0.026 0.053 
rs2854744 0.673 0.317 0.660 0.408 0.161 0.229 0.593 0.878 0.503 
rs2854746 0.319 0.453 0.595 0.260 0.154 0.352 1.000 0.523 0.827 
rs2854747 0.404 0.650 0.671 0.941 0.504 0.238 0.128 0.209 0.547 
rs3793345 0.210 0.326 0.015 0.302 0.427 0.066 0.475 0.721 0.101 
rs2471551 0.307 0.509 0.032 0.254 0.461 0.041 0.882 0.979 0.311 
rs3110697 0.847 0.952 0.289 0.657 0.592 0.095 0.241 0.224 0.739 
rs2453839 0.553 0.763 0.799 0.556 0.778 0.356 0.866 0.976 0.548 
rs6670 0.050 0.111 0.871 0.051 0.100 0.852 0.537 0.766 0.943 
rs13223993 0.549 0.734 0.047 0.108 0.240 0.852 0.003 0.004 0.003 
*p<0.05 in bold 
Cited with permission from Am J Med Genet A, Ester, Weymouth et al., 2009 
 
Table 3.4. 2-SNP Haplotypes* 
NHW Hisp 
SNP 1 SNP 2 p-value p-value 
rs2854747 rs2132571 0.243 0.046 
rs2854747 rs2854744 0.440 0.046 
rs3793345 rs2132572 0.041 0.396 
rs3793345 rs2854744 0.036 0.247 
rs3793345 rs2471551 0.041 0.177 
rs3793345 rs13223993 0.012 0.580 
rs2471551 rs3110697 0.036 0.826 
rs2471551 rs13223993 0.021 0.695 
*Haplotypes with p-value<0.05 in bold. 
Cited with permission from Am J Med Genet 
A, Ester, Weymouth et al., 2009 
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Table 3.5. Gene interactions for HOX and IGFBP3 SNPs* 
NHW Hisp 
Gene 1 SNP 1 Gene 2 SNP 2 p-value p-value 
IGFBP3 rs2854747 HOXA rs6968828 0.003 0.978 
IGFBP3 rs3110697 HOXA rs6968828 0.001 0.943 
IGFBP3 rs13223993 HOXA rs3801776 0.0001 0.890 
IGFBP3 rs3793345 HOXD rs2113563 0.008 0.832 
IGFBP3 rs3793345 HOXD rs2592394 0.003 0.921 
IGFBP3 rs2471551 HOXD rs2113563 0.007 0.687 
IGFBP3 rs2471551 HOXD rs2592394 0.001 0.627 
IGFBP3 rs13223993 HOXD rs741610 0.415 0.002 
IGFBP3 rs13223993 HOXD rs711812 0.272 0.003 
*p-value<0.01 only shown and in bold 
Cited with permission from Am J Med Genet A, Ester, Weymouth et 
al., 2009 
Table 3.6. Gene interactions for IGFBP3 and mitochondrial-
mediated apoptotic SNPs* 
NHW Hisp 
Gene 1 SNP 1 Gene 2 SNP 2 p-value p-value 
APAF1 rs2278361 IGFBP3 rs2132572 0.008 0.888 
APAF1 rs2278361 IGFBP3 rs2453839 0.507 0.002 
APAF1 rs7968661 IGFBP3 rs2132571 0.891 0.007 
APAF1 rs7968661 IGFBP3 rs2453839 0.769 0.006 
APAF1 rs3900115 IGFBP3 rs2854747 0.008 0.750 
CASP3 rs1049210 IGFBP3 rs2854746 0.005  
CASP3 rs1049210 IGFBP3 rs2854744 0.005  
CASP3 rs1049210 IGFBP3 rs2132572 <.0001  
*p-value<0.01 only shown and in bold 
─ value not available 
Cited with permission from Am J Med Genet A, Ester, Weymouth et 
al., 2009 
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3.4. Discussion 
In this study, we assessed whether IGFBP3 has an etiologic role in clubfoot.  Twelve 
IGFBP3 SNPs were genotyped and association was tested in our discovery and validation 
clubfoot datasets.  The strongest association was found for rs13223993 located downstream 
of IGFBP3 and for rs2132572, in a potential regulatory region.  Other SNPs providing only 
suggestive evidence for single SNP and 2-SNP haplotype associations were also in potential 
regulatory regions (Table 3.3).   These results suggest that variants in noncoding regions, 
such as the promoter or enhancer regions have a role in the etiology of clubfoot by 
perturbing gene expression.  
 Clubfoot is a complex disorder caused by multiple genes and environmental 
factors104,108,110.  This assumes that multiple variants, not just one single variant in a gene 
can alter gene function and/or expression.  To evaluate this possibility, we tested for 
potential interactions with variants in other genes previously shown to be associated with 
clubfoot120,121,127.  We found evidence for significant gene interactions with HOXA, HOXD 
and three mitochondrial-mediated apoptotic genes, for example CASP3 (Table 3.5 and 3.6).  
Apoptosis plays a key role in limb and muscle development as one study has shown that 
CASP3 plays a role in muscle and tendon shaping later in limb development46.  Even though 
mitochondrial-mediated apoptotic genes provided only suggestive evidence for a role in the 
etiology of clubfoot, we show significant gene interactions with CASP3 and IGFBP3 (Table 
3.6)121.  These interactions involved rs1049210/CASP3 and three different IGFBP3 
regulatory SNPs (Table 3.6).  Alteration in CASP3 protein function in combination with 
IGFBP3 misexpression could contribute to clubfoot.  Many of the associated gene 
interactions incorporate regulatory SNPs suggesting alteration of expression of multiple 
limb and/or muscle genes could be a key mechanism for clubfoot. 
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Table 3.7. Predicted transcription factor binding sites for associated IGFBP3 SNPs 
Alibaba Patch TESS 
Alleles Alleles Alleles 
SNP Ancestral Alternate Ancestral Alternate Ancestral Alternate 
rs2132572 NFKB, Sp1 None None None None None 
rs3793345 Oct-1 C/EBPalp None None None None 
rs2471551 None None None GATA-1 None None 
Abbreviations: 
NFKB: nuclear factor of kappa light polypeptide gene enhancer in B-cells, Sp1: simian 
virus 40 protein 1, Oct-1: octomer-binding transcription factor 1, C/EBPalp: CCAAT 
Enhancer Binding Protein alpha, GATA-1: GATA binding protein 1 
The association results (Table 3.3) in most cases did not attain significance after 
Bonferroni correction (p<0.004) thus only providing suggestive evidence for association.  
However, it is important to note that the majority of the suggestive associations incorporated 
regulatory SNPs, in particular three SNPs, rs2132572, rs3793345 and rs2471551.  In 
addition, the regulatory SNP, rs2132572, was associated in our validation dataset.  
Regulatory SNPs can alter transcription factor binding and affect gene expression. In silico 
analysis of the three associated regulatory SNPs predict DNA binding to be altered 
depending on the presence of the ancestral or alternate allele (Table 3.7).  These three SNPs 
will need to be further evaluated through functional assays.  Even though these results do 
not meet Bonferroni correction significance, multiple associations incorporating regulatory 
SNPs and in silco analysis predictions further support the importance of regulation of gene 
expression as a key mechanism for clubfoot. 
The results of this study provide a new way of looking at association data from 
which we have developed a model to explain the underlying etiology of clubfoot. We found 
evidence in our single SNP association and interaction analyses for the role of numerous 
regulatory variants in different genes in the development of clubfoot.  All of the genes 
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Figure 3.1. Clubfoot working model. This model incorporates 
associated genes involved in key aspects of limb patterning, apoptosis 
and muscle development along with potential environmental 
influences that could contribute to clubfoot. 
Modified with permission from Am J Med Genet A, Ester, Weymouth 
et al., 2009  
included in this study are those known to play a role in limb and/or muscle development.  
This suggests a model wherein perturbation of gene expression in one gene is not sufficient 
to cause clubfoot.  Rather, it is variation/perturbation of a number of genes that are both 
necessary and sufficient to disturb gene expression thereby affecting limb development.  As 
we show in Figure 3.1, this clubfoot model incorporates genes involved in key aspects of 
limb patterning, apoptosis and muscle development as well as undefined environmental 
influences.  The model suggests that phenotypic expression depends on having a specific 
genetic liability signature; the level of phenotypic severity is likely dependent upon the total 
number of variants across multiple genes.  
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4.1  Introduction 
Nonsyndromic clubfoot, a common, isolated orthopedic birth defect, is characterized 
by equinus, hindfoot varus, forefoot adductus and cavus abnormalities1.  In addition to these 
structural malformations of the foot, calf muscle hypoplasia is present at birth and persists 
even after corrective treatment.  Clubfoot occurs sporadically in the majority of families; 
however, 20-25% of families have at least one other affected individual, but the pattern of 
familial aggregation does not follow a Mendelian mode of inheritance69,71,107,109,110,154,171.  
Concordance in monozygotic twins and segregation analyses provide evidence for a genetic 
etiology69,88,103,104,171,172.  The multifactorial threshold model was developed to explain the 
non-Mendelian inheritance pattern for common birth defects, including clubfoot173-176. 
Recurrence risk estimates for clubfoot families are empiric, derived from family studies and 
incorporate laterality and gender177.  Thus, there is an important need to identify the genetic 
variation underlying clubfoot in order to provide personalized genetic risk assessment. 
Towards this goal, multiple approaches for gene identification have been applied to 
clubfoot families, including interrogation of candidate genes based on biological function or 
location in chromosomal duplication/deletion regions of syndromic clubfoot, genome scans, 
and, more recently, chromosomal microarray analysis (CMA) to identify chromosomal copy 
number variation112-114,120,127,149,178-180.  Thus far, these studies have uncovered only a small 
percentage of the genetic variation underlying clubfoot 112-114,120,121,127,179,181.  Variation in 
two genes, TBX4 and PITX1, has been reported in different families with clubfoot; 
interestingly, TBX4 is a direct transcriptional target of PITX1112-114.  A chromosome 
17q23.1q23.2 microduplication involving TBX4 was identified in four clubfoot families that 
had other skeletal anomalies, suggesting that this is a cause of syndromic clubfoot114.  This 
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represents a rare cause of clubfoot, as more than 600 families were screened and the 
microduplication was identified in only four families. PITX1 was initially implicated in a 
multigenerational clubfoot family, with the identification of a missense mutation 
(E130K)112.  This family had additional skeletal anomalies suggesting this too is a cause of 
syndromic clubfoot.  However, a 241 kb microdeletion involving PITX1 was identified in 
one multiplex clubfoot family with no other anomalies.  Taken together, these data suggest 
that variation in PITX1 can cause both syndromic and non-syndromic forms of clubfoot113.  
PITX1 is a particularly interesting candidate since approximately 9% of Pitx1 
haploinsufficient mice have a clubfoot-like phenotype113. Altogether, the data suggest that 
variation in PITX1 and TBX4 account for less than 1% of familial cases112-114.  Lastly, family 
studies have found suggestive evidence for associations between smoking and apoptotic and 
muscle contracture genes120,121,127,179,182.   Thus, while we have some insight into the causes 
of clubfoot, the vast majority of the underlying genetic liability for nonsyndromic clubfoot 
remains to be identified.  Towards this goal, we submitted ten of our largest nonHispanic 
white (NHW) multiplex clubfoot families for a 6K genome wide linkage screen to identify 
potential candidate regions for clubfoot. 
4.2  Materials and methods 
4.2.1  IRB approval 
This study was approved by the Committee for the Protection of Human Subjects at the 
University of Texas Health Sciences Center at Houston. 
4.2.2  Study population and sample preparation 
Genotyping was performed on 35 affected and 57 unaffected individuals from ten NHW 
multiplex families (Figure. 4.1).  These families were selected based on having 2 or more 
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affected individuals and a sufficient quantity of DNA for the study.   The two largest 
families, F1 and F2, have 11 and 5 affected individuals, respectively, available for 
genotyping, while F3-F10 each have 2-4 affected individuals available.  Probands were 
recruited from outpatient clinics in Shriners Hospitals for Children in Houston, Los Angeles 
and Shreveport and Texas Scottish Rite Hospital for Children of Dallas and the University 
of British Columbia. A standard three-generation pedigree was obtained for all probands and 
extended to include all affected relatives.  All probands and family members underwent 
clinical and radiographic examinations to exclude syndromic cases of clubfoot.  Ethnicity 
was self-reported.  Blood and/or saliva were collected from patients and relevant family 
members. 
DNA was extracted from blood using the Roche DNA Isolation Kit for Mammalian 
Blood (Roche, Switzerland) and from saliva using the Oragene Purifier for Saliva (DNA 
Genotex, Inc., Ontario, Canada) following manufacturer’s protocol.  DNA samples were 
quantified using the Nanodrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA) 
and checked for degradation by running on a 2% agarose gel.   
4.2.3  Genome scan 
DNA samples from 92 individuals (Fig. 4.1) were subjected to the 6K Illumina Linkage 
IVb mapping panel consisting of 6,008 SNPs using a BeadStation system (Illumina Inc., San 
Diego, CA).  Allele detection and genotype calling were performed using the BeadStudio 
software (Illumina Inc., San Diego, CA). 
Genotyping results from the genome scan were subjected to nonparametric and 
parametric linkage analyses using MERLIN (Multipoint Engine for Rapid Likelihood 
Inferences)153.  Two parametric models based on segregation analyses were tested (0.000, 
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0.020, 0.494 and 0.0, 0.008, 0.358 (Model I) and 0.0, 0.002, 0.067 and 0.0, 0.008, 0.033 
(Model II)) for males and females respectively107,109,154. The two large families (F1 and F2) 
were analyzed individually and the remaining families (F3-F10) were analyzed in aggregate, 
allowing for heterogeneity.  
4.2.4  TNNC2 sequencing 
The troponin C2 (TNNC2) gene was sequenced in two clubfoot individuals and one 
unaffected family member from F2, as well as a laboratory control.  Primer sets were 
designed to capture the six exons and the exon/intron junctions (Table 4.1).  PCRs were 
performed in a thermal cycler with 30 cycles of 94ºC for 30 seconds, TmºC (Table 4.1) for 1 
minute and 72ºC for 30 seconds.  PCR products were purified according to manufacturer’s 
protocol (Qiagen, Valencia, CA).  Sequencing results were analyzed using Sequencher v4.8 
(Gene Codes, Ann Arbor, MI). 
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Table 4.1.  TNNC2 primers 
bp: base pair 
 
Exon Forward Primer Reverse Primer bp Tm (°C)
1 GTAATGGGTTCAGACTGTGGG GAAAAGTCAAAGGCCTTCCTCC 366 59
2 TGGGAAGAATGGCTTTGAGGTGA CCACCCTGCCTAGAGGCCACC 201 58
3 GGTAGGTGTGAGGCTGACAGT AGCAGGTGGCAGACTGAGCCTGA 384 62
4 GAGGAGGTGGATGAGGACGGTG CACTCCCAACACGGGGAAGCTTC 308 61
5 GAGGGGCTTAGCAGTCAGAAC GTCGTGGAGCGCTTCTATACC 441 60
6 GTCATCCCCTCTGTGTGGC CCAGCTCCCTTCCACATCC 397 59
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Figure 4.1.  Pedigrees of ten NHW multiplex clubfoot families 
Pedigrees of the ten NHW multiplex clubfoot families (F1-F10) are depicted with shaded 
shapes indicating an individual with clubfoot and an arrow indicating the proband.  
Individuals subjected to the 6 K genome scan are represented with an asterisk. 
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4.3  Results 
A maximum multipoint LOD score of 2.54 was obtained for the 17q23.2 region for 
family F1, and a maximum multipoint LOD of 2.36 was obtained for the 3q22.1-3q24 for F2 
(Tables 4.2 and 4.3).  Additionally, there was suggestive evidence for linkage to 4p14, 
4q32.1, 14q13.1 and 20q13.12-20q13.13 for family F2 (Table 4.3).  TNNC2, a member of 
the muscle contractile apparatus, located in 20q13.12-q13.13, is a good candidate gene for 
clubfoot.  However, no novel variants were found after sequencing the coding region of 
TNNC2 in two affected individuals from F2 (data not shown). 
Suggestive evidence for linkage was found for 14q32.12 (LOD=2.27) and 17q21.33-q22 
(LOD=1.71) (Table 4.4) for families F3-F10. 
 
Table 4.2  Linkage results for F1* 
 
Chr dbSNP base paira Model I 
17q23.2 rs725900 59674303 2.54 
17q23.3 rs4353 61570422 2.34 
17q23.3 rs1043127 61791210 2.32 
17q24.1 rs7591 63525082 2.08 
17q24.1 rs2107654 63633073 2.07 
17q24.2 rs908150 64536433 1.95 
*LOD>1.5 only shown, Chr: chromosomal region 
aBase pair position based on NCBI genome build 37.3 
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Table 4.3. Linkage results for F2* 
 
*LOD>1.5 only shown, Chr: chromosomal region 
aBase pair position based on NCBI genome build 37.3 
  
Chr dbSNP base paira Model I Chr dbSNP base paira Model I
3q22.1 rs1402455 132714125 1.57 4q32.1 rs716428 156506869 1.59
3q22.1 rs1355776 133007112 1.84 14q13.1 rs10147920 34003009 2.01
3q22.1 rs12595 133496553 2.09 14q13.1 rs2027338 34586663 2.30
3q22.2 rs1984630 134414219 2.36 20q13.12 rs244123 43189278 2.34
3q22.2 rs36178 134647169 2.36 20q13.12 rs244099 43225466 2.34
3q22.2 rs750543 135026476 2.36 20q13.12 rs1080026 43413198 2.35
3q22.2 rs1502186 135244629 2.36 20q13.12 rs1003855 43715188 2.35
3q22.3 rs1052620 136574521 2.36 20q13.12 rs1981431 43975451 2.35
3q22.3 rs930984 136940786 2.36 20q13.12 rs411945 44418471 2.35
3q22.3 rs768496 137237541 2.36 20q13.12 rs9074 44688665 2.35
3q22.3 rs751357 138078155 2.36 20q13.12 rs1010310 44835044 2.35
3q22.3 rs531577 138401299 2.36 20q13.12 rs460067 45125293 2.35
3q23 rs1426054 139618657 2.35 20q13.12 rs1046661 45817149 2.35
3q23 rs868534 140275652 2.35 20q13.12 rs1537304 46093212 2.35
3q23 rs1863868 141087623 2.35 20q13.13 rs1547429 46549142 2.35
3q23 rs1709 141331565 2.35 20q13.13 rs761272 47315581 2.34
3q23 rs1479137 142623798 2.34 20q13.13 rs911411 47718431 2.33
3q24 rs765695 143653877 2.32 20q13.13 rs756529 48011008 2.30
3q24 rs1405597 144314276 2.30 20q13.13 rs119416 48035597 2.30
3q24 rs1527732 145299384 2.23 20q13.13 rs718630 49111256 2.05
3q24 rs1398775 145547356 2.18
3q24 rs1024080 145709954 2.13
3q24 rs1707465 145849864 2.02
4p14 rs278973 40396560 2.30
4p14 rs2035383 40688736 2.37
4p14 rs790142 40730503 2.37
4p14 rs951149 41024951 2.36
4p11 rs1350123 48999842 1.93
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Table 4.4.  Linkage results for F3-10* 
 
Chr dbSNP base paira Model I 
14q32.12 rs1242119 93182466 2.07 
14q32.12 rs1740696 93498149 2.16 
14q32.12 rs882023 93532014 2.27 
17q21.33 rs1063647 48187884 1.55 
17q21.33 rs1124281 49849063 1.71 
17q22 rs2033108 53823872 1.57 
* LOD>1.5 only shown, Chr: chromosomal region 
aBase pair position based on NCBI genome build 37.3 
 
 
 
 
4.4  Discussion 
In this study, we subjected 10 multiplex clubfoot families to an Illumina 6K genome-
wide linkage analysis in order to identify chromosomal regions/genes contributing to 
clubfoot. Eight chromosomal regions with a LOD score ≥ 1.5 were identified: 3q22.1-q24, 
4p14-p11, 4q32.1, 14q13.1, 14q32.12, 17q21.33-q22, 17q23.2-q24.2 and 20q13.12.  Only 
one of these regions, 17q23.2-q24.2, has previously been implicated in clubfoot114,118.  The 
remaining seven chromosomal regions are novel and need to be further evaluated for 
candidate clubfoot genes. 
Linkage analysis in F1 identified the 17q23.2-q24.2 region as potentially harboring a 
clubfoot locus.  Subsequently, using copy number and oligonucleotide array CGH testing 
modalities, we identified a 350 kb microduplication in this family118.  As previously 
reported, the microduplication included the complete duplication of TBX4 and NACA2 and 
partial duplication of BRIP1.    Notably, screening all 605 probands in our dataset did not 
identify any other families with a TBX4 duplication118. 
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Linkage analysis from F2 identified five novel regions: 3q22.1-q24, 4p14-p11, 
4q32.1, 14q13.1 and 20q13.12 (Table 4.3).   The 20q13.12 region is of interest because it 
contains TNNC2, a biologically interesting gene because it initiates muscle contraction after 
binding to Ca2+183.  Previously, we reported evidence for association between nonsyndromic 
clubfoot and variation in TNNC2179.  While no novel variants were identified after 
sequencing the coding exons, promoter variants cannot be excluded and should be evaluated 
in future studies. 
The regions identified on chromosomes 3 and 20 contain several biologically 
interesting genes, SOX14 (3q22-q23), PLOD2 (3q24) and NEURL2 (20q13.12),.  NEURL2 
(neutralized homolog 2 also known as Ozz-E3) is a muscle-specific ubiquitin ligase active 
during myogenesis184.   NEURL2 knockout mice develop maturation defects of the 
sarcomeric apparatus which is important for muscle contraction184.  This is relevant as 
human clubfoot is sometimes characterized as a contracture abnormality3,185,186.  Mutations 
in PLOD2 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2) cause Bruck syndrome, a 
rare condition with clinical features of distal arthrogryposis 1 and osteogenesis 
imperfecta187.  Clubfoot has been reported in some affected individuals thus suggesting that 
this gene could play a role in clubfoot187,188.  Lastly, SOX14 is a member of the SOX gene 
family, which is expressed during embryogenesis in a wide range of tissues.  SOX14 is 
expressed in the apical epidermal ridge of the hindlimb, which is important for limb 
outgrowth and patterning189.  In addition, SOX14 has been implicated as a candidate gene for 
limb defects in association with blepharophimosis, ptosis and epicanthus inversus and 
Mobius syndromes189,190.  The limb defects in these conditions include brachydactyly, 
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clinodactyly, syndactyly, metacarpal abnormalities, hypoplasia of the lower legs, and 
clubfoot189-191.   These regions and genes will be considered in future studies.  
Finally, two additional novel regions, 14q32.12 and 17q21.33, were identified in the 
remaining eight families and need to be studied further (Table 4.4).  The 17q21.33 region is 
upstream of the 17q23.1q23.2 microduplication and the linkage results clearly separate the 
regions118.  The 14q32.12 and 17q21.33 regions are large and contain many genes and also 
need to be evaluated further.   
While two genome-wide scans have identified 5q31 as potentially containing 
clubfoot genes, this region was not identified in the current study112,113.  This may be due to 
a number of factors, including the small number of families tested and locus heterogeneity.   
However, the 5q31 region remains interesting because it contains PITX1, a hindlimb specific 
transcription factor, which has been implicated because of mutational events segregating 
with clubfoot in two families and increased frequency of clubfoot in Pitx1 haploinsufficient 
mice112,113.  However, one of these families also had additional skeletal anomalies, 
suggesting that this is a syndromic form of clubfoot and thus would not likely be detected in 
our nonsyndromic clubfoot families112.  Interestingly, this data may also suggest that gene 
regulation may more directly affect foot development with regard to nonsyndromic clubfoot.  
Therefore, evaluation of the regulatory region of PITX1 is warranted in future studies. 
In this study, seven new potential clubfoot regions were identified and provide new 
candidate areas for future studies.  Confirmation in additional familial clubfoot datasets is 
needed to validate the results and narrow these regions in order to identify the genetic 
variation contributing to nonsyndromic clubfoot.   This will then allow for more 
personalized risk counseling for clubfoot families. 
50 
 
 
 
 
 
 
 
 
 
CHAPTER 5: Variation in muscle 
contraction genes contribute to clubfoot 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: The information presented in this chapter was published in 2011, in which I was first 
author: “Variants in genes that encode muscle contractile proteins influence risk for isolated 
clubfoot.” Am J Med Genet A 155A, 2170-9 (2011). Permission for use of the article in this 
dissertation has been obtained from the American Journal of Medical Genetics Part A. 
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5.1 Introduction 
 As previously discussed in Section 1.6.4, a syndromic approach is a viable resource 
in identifying candidate genes.  The hypothesis is that mutations in genes that cause rare 
multiple malformation syndromes that include the phenotype of interest may harbor 
common variants that contribute to the isolated condition.  Distal Arthrogryposis (DA) 
syndromes are a group of rare autosomal dominant disorders characterized by multiple 
congenital joint contractures, including clubfoot and muscle hypoplasia140-148. The feet are 
generally more severely affected than the upper extremities.  Nine different types of DA 
have been delineated and clubfoot is a common characteristic of several of these, including 
DA1, DA2A, and DA2B139.  Mutations in muscle contraction genes, MYH3, TNNT3, TNNI2, 
TPM2 and MYBPC1, have been identified as causes for these DAs with a clubfoot 
phenotype140-148.  The calf muscles of individuals with clubfoot have consistently been 
reported to show a variety of abnormalities including disorganization of muscle fibers, 
increased number of Type I fibers (slow-twitch) and a decrease in Type II fibers (fast-
twitch)3,185,186.  With these observations, muscle contraction genes are plausible candidates 
for isolated clubfoot.  Therefore, interrogation of fifteen muscle contraction genes was 
performed in our clubfoot dataset to assess whether variants in these genes influence the risk 
of clubfoot. 
 
5.2 Materials and Methods 
 Information pertaining to our clubfoot discovery and validation datasets, sample 
collection, DNA extraction, SNP selection, genotyping and analysis (PDT, geno-PDT, APL, 
GEE and transcription factor binding) are described in Chapter 2. 
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 For this analysis, multiple datasets were used.  The discovery dataset consisted of 
224 multiplex families (137 NHW and 87 Hispanic) and 357 simplex families (139 NHW 
and 218 Hispanic), a validation dataset of 142 NHW simplex trios and a case-control 
validation dataset consisting of 616 NHW (308 cases and 308 controls) and 752 Hispanics 
(376 cases and 376 controls).  Seventy-four SNPs spanning fifteen muscle contraction genes 
were selected for evaluation based upon their expression and role in muscle contraction were 
genotyped (Figure 5.1 and Table 5.1). 
  
Log-linear regression models were used to evaluate the independent effects 
of maternal and inherited (child) genotypes for the TNNC2 SNPs that were 
out of HWE in the NHW families192-194.  Specifically, only one triad was 
selected per family consisting of the affected proband and their parents.  For 
each SNP, the likelihood ratio test was used to compare the full model, which 
included parameters for both maternal and inherited genotypes, with reduced 
models, which included parameters for only the maternal or the inherited 
genotype.  In addition, estimates of genotype relative risks and their 
associated 95% confidence intervals were estimated.  All log-linear models 
assumed a log-additive model of inheritance. (cited from Weymouth, et. al, 
Am J Med Genet Part A, 2011) 
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Table 5.1.  Muscle Contraction Gene SNPs 
Genea SNPb Position (bp)c Allelesd Locatione 
MYBPH                 
1q32.1 
rs4950926 201403289 G/A D 
rs2642531 201410348 C/G E3 (missense) 
rs884209 201413912 A/G U 
ACTA1          
1q42.13 
rs728614 227630740 G/A D 
rs506388 227637684 A/C U 
MYL1                     
2q33-q34 
rs867342 210860950 T/C D 
rs2136457 210865694 T/C I5 
rs12469767 210876591 A/C I1/U 
rs1074158 210883288 A/G I1/U 
rs925274 210891742 C/T U 
TPM2                 
9p13.2-p13.1 
rs3750431 35670337 C/G D 
rs1998308 35673882 T/A I8 
rs2145925 35679373 C/T I1 
rs2025126 35686625 G/A U 
TNNI2                 
11p15.5 
rs2292474 1815148 C/T U 
rs1877444 1817801 C/A I2 
TNNT3                     
11p15.5 
rs909116 1898522 T/C I1/U 
rs2734510 1905537 T/C I6/I5 
rs2734495 1915572 T/C I14/I13 
rs7395920 1920888 C/T D 
TPM1                
15q22.1 
rs3809565 61120672 A/G U 
rs4075583 61127280 A/G U/I2 
rs4238371 61134456 C/G I1/I2 
rs12148828 61142392 T/C I8/I7 
rs1972041 61147900 G/A I8/D/I7 
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Table 5.1.  Muscle Contraction Gene SNPs (continued) 
Genea SNPb Position (bp)c Allelesd Locatione 
MYH13                   
17p13 
rs1984620 10141073 C/T D 
rs3744550 10147320 T/C E3 (missense) 
rs11868948 10154767 A/G I8 
rs17690195 10159838 C/T E13 (missense) 
rs2074877 10164439 C/T E17 (missense) 
rs1859999 10169540 G/A I19 
rs2240579 10177190 A/G E23 (syn.) 
rs11869897 10186410 C/T I16 
rs11651414 10192536 A/G I12 
rs4791980 10200165 C/T I8 
rs12936065 10210239 C/T I2 
rs7213488 10220668 G/T U 
rs9906430 10228548 T/C U 
MYH8                 
17p13.1 
rs9906430 10228548 T/C D 
rs2270056 1023622 T/C I50 
rs7211175 10237747 A/C I47 
rs3744552 10244986 A/G E32 (syn.) 
rs12601552 10255100 G/A I14 
rs2277648 10265705 C/T I2 
rs11078846 10269685 A/T U 
MYH4                      
17p13.1 
rs11654423 10286056 C/T D 
rs2058101 10295699 T/C I27 
rs2058099 10303471 A/G I14 
rs2011488 10311370 C/A I2 
MYH1                 
17p13.1 
rs8077200 10331008 A/G U 
rs3744563 10340622 A/G I33 
rs2320950 10348281 A/G I22 
rs8082669 10358592 G/A I6 
rs9916035 10364565 T/C U 
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Table 5.1.  Muscle Contraction Gene SNPs (continued) 
Genea SNPb Position (bp)c Allelesd Locatione 
MYH1                      
17p13.1 
rs8077200 10331008 A/G U 
rs3744563 10340622 A/G I33 
rs2320950 10348281 A/G I22 
rs8082669 10358592 G/A I6 
rs9916035 10364565 T/C U 
MYH2                      
17p13.1 
rs9916035 10364565 T/C D 
rs7223755 10367068 T/C I39 
rs2277651 10373363 T/C I25 
rs2277653 10383702 T/C I12 
rs3760431 10393038 A/G I2 
rs4239117 10396857 G/T U 
MYH3                     
17p13.1 
rs2285475 10483196 C/A E25 (syn.) 
rs876657 10485141 A/C E19 (syn.) 
rs2239933 10489909 T/C I11 
rs201622 10518759 C/G U 
MYBPC2              
19q13.33 
rs12462762 55633501 G/A I7 
rs10405793 55640362 A/T I11 
rs25665 55649209 G/A E17 (missense) 
rs25667 55659452 G/A E27 (missense) 
rs1274597 55665071 G/A D 
TNNC2                 
20q12-
q13.11 
rs3848711 43879507 T/C D 
rs8860 43885308 G/A 3' UTR 
rs4629 43886104 G/T E5 (syn.) 
rs437122 43888385 C/T I1 
rs373018 43889466 C/T U 
rs380397 43890062 T/G U 
rs383112 43890756 C/T U 
U, upstream; D, downstream; I, intron; E, exon; S, synonymous; M, missense 
aGene name and chromosomal location 
bSNP data source; NCBI map – genome build 36.3 
cBase pair position 
dMajor allele listed first based upon NCBI listing 
eSNP gene location 
Cited with permission from Am J Med Genet Part A, Weymouth, et. al, 2011 
 Figure 5.1. The muscle contractile apparatus 
The fifteen muscle contraction genes interrogated in our clubfoot 
represented here.  Gene name color correlates with location in the apparatus.  A
Arthrogryposis with a clubfoot phenotype.
 
dataset are involved in various aspects of muscle contraction and are 
sterisks depict genes implicated in 
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a type of Distal 
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5.3 Results 
None of the SNPs in TNNC2 were in HWE in the NHW discovery dataset 
and were removed from the association analyses; all remaining SNPs in the 
NHW were in HWE.  All TNNC2 SNPs were in HWE in the Hispanic dataset 
and were therefore included in the association analyses.  Only rs2074877 in 
MYH13 was out of HWE in the Hispanic discovery dataset and was removed 
from analyses.  Allele frequencies differed significantly between the NHW 
and Hispanic groups for SNPs in 14 of the 15 examined genes.  Therefore, 
the data were stratified by ethnicity.  Parametric and nonparametric linkage 
analysis found no evidence for linkage (data not shown). 
 Overall, nominal evidence for association was found for SNPs in 12 
of 15 genes in the discovery datasets (p<0.05; Table 5.2).  For the NHW 
dataset, evidence for association was seen for SNPs in six genes: MYBPH, 
TPM2, TNNT3, TPM1, MYH13, and MYH3 (Table 5.2A).  Three SNPs in 
MYH3 had altered transmission primarily in the NHW multiplex subset.  All 
other associations involved a single SNP in each of the five other genes.  In 
the Hispanic dataset, there was evidence for altered transmission in 11 genes 
(Table 5.2B).  Five of these genes, MYBPH, TPM2, TNNT3, TPM1, and 
MYH13, also had SNPs with altered transmission in the NHW dataset; only 
one SNP was common to both datasets (MYH13/rs17690195).  In addition, 
several genes had multiple SNPs with altered transmission [MYL1(3), 
TNNT3(3), MYH8(4), MYH4(3), MYH1(2), and MYH2(2)]. 
 When 2-SNP haplotypes were considered, altered transmission was 
found for five genes in the NHW group (p<0.01; Table 5.3A).  Two of these 
genes, ACTA1 and MYH8, did not have individually altered transmitted 
SNPs.  Three different MYH13 haplotypes had altered transmission; none of 
the haplotypes included the individual SNPs with altered transmission (Table 
5.3A).  The two TPM2 haplotypes both contained rs1998303, which had 
altered transmission in the single SNP analyses.  In the Hispanic discovery 
dataset, three MYH13 haplotypes had altered transmission (Table 5.3B); only 
one contained rs17690195, which had altered transmission in the single SNP 
analysis (Table 5.2B).  There was no overlap between the NHW MYH13 
haplotypes and the Hispanic MYH13 haplotypes, and only one SNP 
(MYH13/rs2240579) was common to both ethnicities. 
 Numerous potential gene interactions were identified in both the 
NHW and Hispanic discovery datasets (p<0.01; Table 5.4).  The only gene 
interaction present in both datasets was TPM1 and MYH13, although the 
same SNPs were not involved in the two datasets.  SNPs in ACTA1, MYH1, 
MYH13, MYH2, MYH4, MYH3, MYH8, MYL1, TNNT3, TPM1, and TPM2 
were involved in interactions in both ethnic groups. 
Three genes (TNNI2, MYBPC2, and TNNC2) did not have any SNPs 
meeting our criteria for follow-up in the validation datasets.  In the family-
based validation dataset, only two SNPs in the single SNP analyses 
demonstrated any evidence for altered transmission, TNNT3/rs2734495 
(p=0.04) and TPM1/rs1972041 (p=0.000074; data not shown).  The TPM1 
result is supported by the 2-SNP analyses in the validation dataset where only 
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TPM1 haplotypes had altered transmission (Table 5.5).  All four of the 
significant haplotypes contained rs1972041.  In the case-control dataset, only 
nominal evidence for association was seen with rs1248828 in TPM1 (p=0.04) 
in the Hispanic subset; there were no associations in the NHW subset (data 
not shown). 
Further examination of the NHW maternal, paternal, and proband 
TNNC2 genotype frequencies revealed that only the maternal genotypes 
deviated from HWE, suggesting the presence of a maternal genetic effect. 
Table 5.6 summarizes the results of log-linear models assessing maternal and 
inherited genotypic effects.  For rs383112, significant associations were 
observed with both the maternal and inherited genotypes (p=0.02 and 0.03, 
respectively).  The maternal genotype for rs393112 was associated with 1.38-
fold increased risk (CT vs. CC; 95% CI: 1.13-1.72) of clubfoot in offspring, 
while a protective inherited genotypic effect was conferred with a relative 
risk of 0.77 (CT vs. CC; 95% CI: 0.50-0.99).  In addition, a significant 
protective inherited genotypic effect (p=0.02), with a relative risk of 0.74 
(TG vs. TT; 95% CI: 0.48-0.97), was found for rs4629. (cited from 
Weymouth, et. al, Am J Med Genet Part A, 2011) 
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Table 5.2.  Single SNP Association by Ethnicitya,b 
A. NHW 
    ALL   Multiplex   Simplex   
Gene SNP APL PDT GENO-PDT 
 
APL PDT GENO-PDT 
 
APL PDT GENO-PDT   
MYBPH rs4950926 0.149 0.477 0.733 0.021 0.128 0.179 0.812 0.413 0.447   
TPM2 rs1998308 0.003 0.065 0.056 0.090 0.322 0.228 0.009 0.027 0.091   
TNNT3 rs2734495 0.019 0.043 0.088 0.220 0.176 0.397 0.062 0.096 0.113   
TPM1 rs4075583 0.014 0.519 0.700 0.221 0.694 0.723 0.031 0.027 0.028   
MYH13 rs17690195 0.065 0.256 0.250 0.039 0.144 0.216 0.674 0.873 0.749   
MYH3 rs2285475 0.442 0.091 0.242 0.042 0.020 0.081 0.364 0.696 0.861   
MYH3 rs876657 0.399 0.039 0.109 0.021 0.006 0.020 0.345 0.696 0.926   
MYH3 rs223993 0.320 0.104 0.211   0.030 0.058 0.161   0.705 0.884 0.848   
 
B. Hispanic 
  
ALL 
 
Multiplex 
 
Simplex 
Gene SNP APL PDT GENO-PDT APL PDT GENO-PDT APL PDT GENO-PDT 
MYBPH rs884209 0.045 1.000 0.886 0.388 0.564 0.282 0.068 0.612 0.544 
ACTA1 rs728614 0.299 0.053 0.227 0.095 0.398 0.737 0.812 0.024 0.050 
MYL1 rs867342 0.059 0.016 0.069 0.637 0.196 0.413 0.062 0.024 0.122 
MYL1 rs2136457 0.034 0.021 0.099 0.198 0.168 0.439 0.115 0.047 0.187 
MYL1 rs12469767 0.108 0.020 0.083 — 0.206 0.454 0.113 0.048 0.156 
TPM2 rs3750431 0.089 0.147 0.070 0.094 0.084 0.145 0.350 0.806 0.008 
TNNT3 rs909116 0.628 1.000 0.138 0.018 0.527 0.062 0.284 0.292 0.440 
TNNT3 rs2734510 0.143 0.697 0.361 0.016 0.607 0.208 0.746 0.912 0.876 
TNNT3 rs7395920 0.023 0.006 0.024 0.110 0.031 0.069 0.095 0.085 0.184 
TPM1 rs1972041 0.017 0.167 0.387 0.249 0.691 0.846 0.039 0.149 0.337 
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Table 5.2.  Single SNP Association by Ethnicity (continued)a,b 
B. Hispanic  
 
  
ALL 
 
Multiplex 
 
Simplex 
Gene SNP APL PDT GENO-PDT APL PDT GENO-PDT APL PDT GENO-PDT 
 
MYH13 rs17690195 0.038 0.003 0.010 N/A 0.043 0.084 0.141 0.029 0.063 
 MYH13/ 
MYH8 rs9906430 0.300 0.116 0.352  0.804 0.814 0.664  0.151 0.005 0.014  
MYH8 rs2270056 0.157 0.401 0.156 0.763 0.898 0.880 0.150 0.174 0.042 
 
MYH8 rs12601552 0.229 0.015 0.103 — 0.353 0.395 0.261 0.016 0.021 
 
MYH8 rs2277648 0.012 0.028 0.089 0.124 0.132 0.225 0.056 0.107 0.312 
 
MYH8 rs11078846 0.174 0.052 0.076 0.445 0.385 0.734 0.301 0.059 0.031 
 
MYH4 rs11654423 0.206 0.016 0.112 — 0.103 0.232 0.293 0.077 0.155 
 
MYH4 rs2058099 0.070 0.027 0.121 0.376 0.431 0.613 0.144 0.020 0.025 
 
MYH4 rs2011488 0.161 0.018 0.055 0.169 0.276 0.634 0.478 0.024 0.030 
 
MYH1 rs8077200 0.872 0.677 0.732 0.106 0.194 0.152 0.079 0.010 0.026 
MYH1 rs3744563 0.052 0.050 0.153 0.683 0.884 0.617 0.061 0.015 0.018 
MYH2 rs2277651 0.092 0.038 0.121 0.891 0.362 0.386 0.064 0.050 0.193 
MYH2 rs3760431 0.223 0.037 0.145 
 
— 0.327 0.584 
 
0.128 0.056 0.080 
NHW, nonHispanic White; —, no value because of low APL variance 
aSNPs with p<0.05 shown in bold 
bp-values uncorrected for multiple testing. 
Cited with permission from Am J Med Genet Part A, Weymouth, et. al, 2011 
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Table 5.3. 2-SNP Haplotype Transmission – Discovery Populationa,b 
 
A. NHW 
Gene SNP A SNP B p-value 
ACTA1 rs728614 rs506388 0.008 
MYH8 rs2270056 rs3744552 0.008 
MYH13 rs11868948 rs1859999 0.007 
MYH13 rs3744550 rs1859999 0.004 
MYH13 rs3744550 rs2240579 0.00004 
TPM2 rs1998308 rs2145925 0.006 
TPM2 rs1998308 rs2025126 0.006 
TNNT3 rs2734495 rs2734510 0.002 
 
B. Hispanic 
Gene SNP A SNP B p-value 
MYH13 rs1984620 rs4791980 0.0006 
MYH13 rs2240579 rs7213488 0.008 
MYH13 rs17690195 rs7213488 0.007 
 
ap-values not corrected for multiple testing 
bonly p-values<0.01 shown 
Cited with permission from Am J Med Genet Part A, Weymouth, et. al, 2011
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Table 5.4. Gene Interactions Between SNPs in Different Muscle Contraction Genesa,b 
 
A. NHW 
 
Gene A SNP 1 Gene B SNP 2 p-value 
ACTA1 rs506388 MYBPC2 rs1274597 0.007 
ACTA1 rs728614 MYH1 rs2320950 0.004 
ACTA1 rs506388 MYH13 rs2074877 0.008 
ACTA1 rs728614 MYH13 rs1859999 0.009 
MYL1 rs867342 MYH1 rs3744563 0.009 
MYL1 rs867342 MYH8 rs2270056 0.009 
MYL1 rs867342 MYH8 rs11078846 0.006 
MYH4 rs2058101 MYH3 rs201622 0.007 
MYH8 rs3744552 MYH1 rs8077200 0.007 
MYH8 rs3744552 MYH1 rs3744563 0.008 
MYH8 rs3744552 MYH4 rs2058099 0.004 
TPM1 rs1972041 MYH1 rs2320950 0.003 
TPM1 rs12148828 MYH13 rs1984620 0.007 
TPM2 rs1998308 MYH2 rs2277651 0.003 
TPM2 rs1998308 MYH2 rs3760431 0.008 
TPM2 rs1998308 MYH4 rs2058101 0.006 
TPM2 rs1998308 MYH4 rs2011488 0.006 
TNNT3 rs2734495 MYH4 rs2058099 0.003 
TNNT3 rs7395920 TPM1 rs3809565 0.008 
ap-values not corrected for multiple testing 
bonly p-values<0.01 shown 
Cited with permission from Am J Med Genet Part A, Weymouth, et. al, 2011 
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Table 5.4. Gene Interactions Between SNPs in Different Muscle Contraction Genes 
(continued)a,b 
B. Hispanic 
Gene A SNP 1 Gene B SNP 2 p-value 
ACTA1 rs728614 MYL1 rs1074158 0.002 
MYBPH rs4950926 TNNI2 rs1877444 0.005 
MYH1/MYH2 rs9916035 MYH3 rs2239933 0.004 
MYH1/MYH2 rs9916035 MYH3 rs2285475 0.009 
MYH13 rs17690195 TPM1 rs12148828 0.006 
MYH13 rs1859999 TPM1 rs3809565 0.004 
MYH13 rs1859999 MYH2 rs7223755 0.006 
MYH13 rs2240579 MYH3 rs2285475 0.007 
MYH13 rs12936065 TPM2 rs2025126 0.007 
MYH13 rs12936065 TNNT3 rs909116 0.002 
TNNC2 rs4629 MYBPH rs2642531 0.002 
TNNC2 rs4629 TPM2 rs2025126 0.002 
TNNC2 rs4629 TPM2 rs3750431 0.002 
TNNC2 rs4629 MYBPC2 rs25665 0.006 
TNNC2 rs3848711 MYBPH rs2642531 0.002 
TNNC2 rs3848711 MYBPC2 rs25665 0.006 
TNNC2 rs3848711 TNNT3 rs2734510 0.006 
TNNC2 rs383112 MYBPH rs2642531 0.003 
TNNC2 rs383112 MYBPC2 rs25665 0.006 
TNNC2 rs383112 MYBPC2 rs25667 0.006 
TNNC2 rs383112 MYH4 rs2058099 0.008 
TNNC2 rs437122 MYH1 rs8077200 0.009 
TNNC2 rs437122 MYH8 rs2270056 0.009 
ap-values not corrected for multiple testing 
bonly p-values<0.01 shown 
Cited with permission from Am J Med Genet Part A, Weymouth, et. al, 2011
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Table 5.5. 2-SNP Haplotype Transmission – Validation Populationa,b 
Gene SNP A SNP B p-value 
TPM1 rs1972041 rs3809565 <0.00000 
TPM1 rs1972041 rs4075583 0.000009 
TPM1 rs1972041 rs4238371 0.0002 
TPM1 rs1972041 rs12148828 0.0002 
ap-values not corrected for multiple testing 
bonly p-values<0.01 shown 
Cited with permission from Am J Med Genet Part A, Weymouth, et. al, 2011
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Table 5.6. Results of Log-Linear Modeling for TNNC2 in the NHW Case-Parent Triadsa,b 
 
SNP RR Child (95% CI) RR Mom (95% CI) LRT Child p-value LRT Mom p-value 
rs4629 0.74 (0.48-0.97) 1.27 (1.03-1.61) 0.02 0.11 
rs8860 0.80 (0.94-1.53) 1.20 (0.54-1.04) 0.08 0.22 
rs380397 1.24 (1.00-1.53) 0.81 (0.48-1.09) 0.11 0.18 
rs383112 0.77 (0.50-0.99) 1.38 (1.13-1.72) 0.03 0.02 
rs437122 0.79 (0.52-1.03) 1.23 (0.97-1.58) 0.08 0.17 
rs3848711 0.80 (0.54-1.03) 1.23 (0.97-1.56) 0.07 0.17 
CI, confidence interval; RR, relative risk; LRT, likelihood ratio test 
ap-value<0.05 and significant CI in bold 
bRelative risk of the heterozygote compared to the common homozygotes 
Cited with permission from Am J Med Genet Part A, Weymouth, et. al, 2011 
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Table 5.7.  Predicted Transcription Factor Binding Sites 
  
Alibaba 2 
 
Patch 
 
TESS 
SNP Gene Ancestral Alternate 
 
Ancestral Alternate 
 
Ancesteral Alternate 
rs3809565 TPM1 None None 
 
None c-myb 
 
RC2 None 
rs4075583 TPM1 None None 
 
Lef-1, 
RUNX2 
c-myc,                
c-myb  None c-myc 
rs9906430 MYH13 None None 
 
None HIF1A 
 
NF-E NF-E 
rs383112 TNNC2 None AP-2, Sp1,    NF-1  None None  None None 
rs437122 TNNC2 NF-1 NF-1 
 
c-FOS, AP-
1,      CRE-
BP1, CREB 
NF-E,           
PKNOX1  CREB 
NF-E,        
GAL4 
rs2025126 TPM2 MT2A,      
c-jun None  HNF1-A None  
NF-1, CP2, 
CEBPZ None 
rs2145925 TPM2 NF-1 SP-1 
 
ETV4 None 
 
NF-1 None 
rs909116 TNNT3 None None 
 
LXR-alpha, 
LXR-beta, 
RXR-alpha 
None 
 
AP-1, ER, 
ER-alpha RAF 
 
RUNX2, runt-related transcription factor 2; LEF1, lymphoid enhancer-binding factor 1; c-myc, v-myc myelocytomatosis viral 
oncogene homolog (avian); c-myb, v-myb myeloblastosis viral oncogene homolog (avian); HIF1A, hypoxia inducible factor 1, 
alpha subunit; NF-E, nuclear factor E; AP-1/2, activating enhancer binding protein 1/2; NF-1, neurofibromin1; Sp1, simian virus 40 
protein 1; MT2A, metallothionein 2A; c-jun, jun proto-oncogene; CP2, ceruloplasmin; CEBPZ, CCAAT/enhancer binding protein 
(C/EBP), zeta; HNF1A, HNF1 homeobox A; ETVA, ets variant 4; LXR-alpha, liver X receptor, alpha; LXR-beta, liver X receptor, 
beta; RXR-alpha, Retinoid X receptor alpha; ER, estrogen receptor; ER-alpha, estrogen receptor, alpha; RAF, rapidly accelerated 
fibrosarcoma; c-FOS, FBJ murine osteosarcoma viral oncogene homology; PKNOX1, Pbx/knotted 1 homeobox; GAL4, 
galactoside-binding, soluble 4
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5.4 Discussion 
 The focus of this study was to assess whether variants within muscle contraction 
genes have an etiologic role in clubfoot.  We report the first evidence for maternal and 
inherited genotypic effects involving two TNNC2 SNPs, rs4629 and rs383112, in the NHW 
group.  Strong evidence for association was found for SNPs located in TPM1 and TPM2 for 
the NHW group (Table 5.2A).  In the Hispanic group, the strongest association was with 
MYH13 and TNNT3 SNPs.  Interestingly, as seen previously with IGFBP3 (Chapter 3), 
multiple associations incorporated regulatory SNPs further suggesting regulation of gene 
expression as a key mechanism for clubfoot.  These results suggest common variants within 
muscle contraction genes, in particular TNNC2, TPM1 and TPM2, play an etiological role in 
clubfoot. 
  Evidence for genotypic effects was observed with 2 TNNC2 SNPs, rs383112 and 
rs4629, in the NHW group (Table 5.6).  A deleterious maternal effect was found for 
rs383112, while a protective effect was observed for rs4629.  TNNC2 encodes troponin C 
which plays a key role in initiating muscle contraction in fast-twitch muscles by binding 
Ca2+ causing a conformational change that releases troponin T’s inhibition and allowing for 
actin and myosin to interact183,195.  The SNP, rs4629 located in exon 5, causes a synonymous 
change with the alternate allele.  Synonymous changes can affect translation rate and cause 
changes to protein structure and function196,197.  The deleterious maternal effect SNP, 
rs383112, is located 1.5 kb upstream of the start site.  In silico analysis of rs383112 predicts 
alteration in transcription factor binding depending on the presence of the ancestral or 
alternate allele (Table 5.7).  The genotypic effects of each of these SNPs could alter protein 
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function/or expression.  Though our genotypic effects are very interesting, additional 
independent datasets need to be assessed for these genotypic effects. 
 In our NHW discovery group, evidence for association was found with SNPs in 
TPM1 and TPM2, which encode members of the tropomyosin family, a key component in 
regulating the interaction of actin and myosin during muscle contraction183,195.  TPM1 is 
expressed in fast-twitch muscle fibers, while TPM2 is expressed in slow-twitch muscle 
fibers. An intronic SNP, rs1998308 in TPM2, showed suggestive evidence for association in 
our discovery dataset (p=0.003).  In addition, 2-SNP haplotype analysis identified two 
associated haplotypes incorporating rs1998308 with two potential regulatory SNPs, 
rs2025126 and rs2145925 that are predicted to alter DNA binding (Table 5.7).    TPM1 
SNPs were associated in all three datasets, discovery, validation and case-control, albeit with 
different SNPs.  One of these associated SNPs, rs4075583, is located in a potential 
regulatory region and predicted to alter DNA binding (Table 5.7), while rs1972041 and 
rs12148828 are either intronic or downstream depending on the TPM1 isoforms.  Multiple 
TPM1 isoforms are produced through alternate splicing and expression is tissue specific198.  
Three TPM1 regulatory SNPs, including our associated rs4075583, are associated with 
Metabolic Syndrome and were evaluated for their effect on the expression of the short 
TPM1 isoform198,199.  The presence of the ancestral allele (G) of rs4075583 (the risk allele in 
our NHW group) decreased gene expression in human embryonic kidney cells (HEK293)199.  
Altered gene expression could affect muscle contraction and needs to be further evaluated in 
biologically relevant cells such as muscle cells. 
 In our Hispanic discovery group, the strongest evidence for association was with 
SNPs in TNNT3 and MYH13.  Troponin T type 3 (TNNT3) is expressed in fast-twitch 
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skeletal muscle fibers and is the subunit of the troponin complex that binds the complex to 
tropomyosin which regulates muscle contraction183.  Myosin heavy chain 13 (MYH13) is a 
key component of the thick filament that interacts with actin to allow for muscle contraction.  
Two MYH13 SNPs, rs9906430, located in a potential regulatory region and predicted to alter 
DNA binding, and rs17690195, an exonic SNP that creates a missense mutation, were 
associated in the discovery group (Table 5.7).  Three TNNT3 SNPs were associated 
including one potential regulatory SNP, rs909116, that is predicted to alter DNA binding 
(Table 5.7).  Interestingly, mutations in TNNT3 have been implicated in DA2B, which has a 
clubfoot phenotype145.  However, a previous study evaluating the coding regions of three 
skeletal muscle contraction genes, TNNT3, TPM2 and MYH3 identified no coding mutations 
but the regulatory regions of these three genes were not evaluated149.  
  As shown in Figure 5.1, muscle contraction is a well-orchestrated process involving 
multiple proteins183.  The combination of variants in multiple muscle contraction genes 
could alter muscle contraction and contribute to clubfoot.  Multiple potential variant 
interactions were associated in both the NHW and Hispanic discovery dataset (Table 5.4A 
and B).  These interactions could not be confirmed in our validation datasets possibly due to 
small sample size.  Interestingly, many of these associated interactions incorporated at least 
one regulatory SNP.  Risk variants in multiple muscle contraction genes could lead to 
alteration in gene function and/or expression contributing to susceptibility of clubfoot. 
 This study is the first to identify genotypic effects with SNPs in TNNC2 for clubfoot.  
In addition, we showed that a syndromic approach is a valuable technique to use in 
identifying candidate genes for isolated conditions.  For example, mutations in TNNT3 and 
TPM2 have been identified to cause syndromic clubfoot associated with DAs and we found 
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common variants within these genes that are associated with isolated clubfoot. Utilizing 
additional genes involved in muscle contraction, we were able to identify another novel 
gene, TPM1, to be associated with isolated clubfoot.  Once again, multiple associations 
involved potential regulatory SNPs; these SNPs need to be further evaluated through 
functional assays to assess their implications on expression so we can begin to understand 
their role in the etiology of clubfoot.  Furthermore, this study supports the importance of 
genes involved in muscle contraction and development as key factors to the genetic etiology 
of clubfoot and should be a focus for future association studies179. 
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6.1 Introduction 
Clubfoot is a common complex birth defect characterized by the inward posturing of 
the foot in a rigid, downward position with significant calf muscle hypoplasia1-3.   Both 
genetic and environmental factors have been suggested to play an etiologic role in this 
orthopedic birth defect.  However, maternal smoking is the only exogeneous factor that has 
consistently been associated with clubfoot93,102,200.   How maternal smoking affects foot 
development remains to be determined.  There are numerous lines of evidence supporting a 
role for genes including (1) twin studies showing a higher concordance in monozygotic 
(33%) than dizygotic twins (3%), (2) increased relative risk of a child being affected when a 
parent and sibling are affected (10-20%), (3) 72% heritability and (4) segregation 
analyses88,103,108,172.  Multifactorial inheritance is widely accepted as a model for clubfoot 
inheritance73,88,103,108,172,178,181,201. 
Candidate gene and GWAS approaches have been applied to clubfoot datasets and 
large multiplex families with varying levels of success64,112-114,118,120,121,125,127,149,179,181,182,202.  
The most interesting results to date involve TBX4 and PITX1, two genes that play significant 
limb patterning roles115-117.  These genes were identified in studies scanning families for 
associated genes.  A microduplication located on 17q23 has been identified in two 
independent studies and is particularly interesting since it contains TBX4, a transcription 
factor expressed specifically in the hindlimb and plays an important role in muscle 
patterning115,116.  The four clubfoot families with the 17q23 microduplication also had 
family members with other skeletal anomalies such as short wide feet, enlargement of the 
distal fibular head and shortened calcaneus114,118.    However, association analysis of eleven 
TBX4 SNPs in a large clubfoot dataset consisting of families with and without a family 
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history of clubfoot found no significant association118.  Thus, this microduplication is a rare 
cause for familial clubfoot and is more suggestive of a syndromic form of clubfoot/foot 
anomalies that are not typically reported with isolated clubfoot.   
Interestingly, TBX4 is a direct transcriptional target of PITX1117.  PITX1, a 
transcription factor required for hindlimb development has also been implicated in 
clubfoot6,9,112,113.  A genome-wide study found linkage to 5q31 in one five-generation family 
in which clubfoot segregated with incomplete penetrance112.  PITX1, in the 5q31 linkage 
region, was sequenced and a missense mutation (E130K) in a highly conserved 
homeodomain was found and segregated with the disease phenotype in the family112.  
Decrease in PITX1 expression was observed in a dose-dependent manner, thus suggested to 
have a dominant-negative effect on transcription112.  A microdeletion involving the same 
5q31 region containing PITX1 was found in a second family with clubfoot.  The pattern of 
phenotypic findings suggests that alteration of PITX1 expression contributes to syndromic 
clubfoot rather than the nonsyndromic type113.  However, in support of the role of PITX1 in 
nonsyndromic clubfoot, 8.9% of Pitx1 heterozygote knockout mice had a clubfoot-like 
phenotype113.   
A recent study by Alvarado et al. (2012) evaluated copy number variants (CNVs) in 
413 clubfoot probands and compared them to 759 controls.  Although there was no 
difference between number of CNVs in cases and controls, 9 new CNVs segregated with the 
disease phenotype.  Using a gene expression array on E12.5 mouse hindlimb bud, four 
biologically relevant genes, HOXC13, RIPPLY2, CHD and UTX, were identified in the new 
CNV regions.  HOXC13 is a member of the homeobox C gene cluster and is differentially 
expressed in the hindlimb, while CHD and UTX have a functional role in regulating the 
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HOXC13 genes203-205.  RIPPLY2 regulates T-box transcription factors during 
embryogenesis206.  These interesting results suggest a potential hindlimb transcriptional 
regulatory pathway that may contribute to clubfoot. 
In previous studies, we investigated genes involved in hindlimb skeletal muscle 
patterning, development and contraction127,179.  Mutations in these genes cause a range of 
syndromes that have limb anomalies such as brachydactyly to Distal Arthrogryposis with 
clubfoot125,126,139-148,165,207.  The HOXA and D gene clusters were interrogated because of 
their roles in limb and muscle patterning and development.  Mutations in these gene clusters 
cause limb anomalies; for example HOXD13 mutations can cause synpolydactyly and 
brachydactyly165,207.  In addition, mutations in muscle contraction genes (MYH3, TNNT3, 
TNNI2, TPM2 and MYBPC1) cause a spectrum of Distal Arthrogryposis disorders many of 
which have muscle hypoplasia and clubfoot as part of the phenotype22,37-46.  Association 
analysis of these muscle patterning and contraction genes found positive associations with 
SNPs in the regulatory regions of four genes, rs3801776/HOXA9, rs3809565/TPM1, 
rs4075583/TPM1, rs2025126/TPM2, rs2145925/TPM2, rs383112/TNNC2 and 
rs437122/TNNC2127,179.  In silico analyses of these SNPs predict allele-dependent 
transcription factor binding sites that could affect gene expression.  We hypothesized that 
variation in expression of one or more of these genes involved in skeletal muscle patterning 
and function might contribute to nonsyndromic clubfoot.  In these studies, we performed 
functional analysis of seven SNPs to better understand the biologic role of SNP variation in 
the regulatory regions of TPM1, TPM2, TNNC2 and HOXA9. 
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6.2 Materials and methods 
6.2.1 Electrophoretic mobility shift assays (EMSA) 
Genomic sequences were obtained from NCBI (http://www.ncbi.nlm.nih.gov) and 
the oligonucleotide probes were designed to incorporate approximately 10 base pairs 
upstream and downstream from the SNP location to create 20 nucleotide DNA probes 
(20mers).    Oligonucleotides were synthesized by Integrated DNA Technologies 
(Coralville, IA) (Table 6.1).  The double stranded DNA 20mer probes were generated by 
annealing complementary oligonucleotides and end-labeling with corresponding 
radiolabeled α-32P nucleotides on the forward strand (Perkin Elmer, Waltham, MA).  
Nuclear extracts from EMSAs were carried out by incubating 4.5 µg (undifferentiated) or 
5.00 µg (differentiated) nuclear extract with radiolabeled probe in a 20 µl incubation mixture 
containing 20mM Tris pH 7.5, 50mM KCl, 10% glycerol, 0.5 mM EDTA, 0.5mM DTT, 
0.05% NP-40, 1mM PMSF and 1 µL of dG/dC (Sigma-Aldrich, St. Louis, MO).  After 
incubation at 4ºC for 1 hour, the samples were loaded on 5% polyacrylamide gels that had 
been prerun for 30 min at 150V in 1X TBE.  After electrophoresis (150V) for 2½ hours at 
room temperature, the gels were dried and radioactive signals were visualized by exposure 
to a radiograph film at -80°C for 18-36 hrs. 
6.2.2 Cell culture technique 
C2C12 mouse muscle cells (ATCC# CRL-1772) were obtained from the American 
Type Culture Collection (ATCC, Manassas, VA).  For the undifferentiated cells, the cells 
were expanded using standard techniques in Gibco® DMEM High Glucose medium (Life 
Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum.  To initiate 
differentiation, cells were first washed with PBS and media was changed to Gibco® DMEM 
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High Glucose medium (Life Technologies, Grand Island, NY) supplemented with 5% horse 
serum. 
6.2.3 Generation of TPM1, TPM2, TNNC2 and HOXA9 promoter constructs 
Promoter constructs were designed for TPM1, TPM2, TNNC2 and HOXA9 to 
evaluate promoter activity.  Since promoter regions for TPM1 and TPM2 are not well-
defined, we designed constructs to incorporate approximately 500 base pairs upstream from 
the transcriptional start site since most of the promoter elements are found in this 
region208,209.  For TPM1, the skeletal muscle isoform was targeted (NM_001018005.1) and 
the promoter region of TNNC2 is well characterized and  includes 1,625 base pair region 
upstream of the transcriptional start site which includes a necessary upstream regulatory 
element (URE) for activity210.  Primers were designed to incorporate 5’-Xho I and 3’- Bgl II 
cut sites for ligation into the double digested pGL4.10 luciferase basic vector (pGL4.10, 
Promega, Madison, WI) using the In-Fusion® HD Cloning System (Clontech, Mountain 
View, CA).  BAC clones containing TPM1 (RP11-244F12) and TPM2 (RP-112J3) were 
amplified to create the ~500 bp inserts using TPM1 primer set (500 bp, Tm: 55ºC) forward 
primer, gctcgctagcctcgagCGCGCTCTCCCGGCCTCCGGC and reverse primer, 
cgccgaggccagatctGGTGGCGGCGGCGAGGGGCC and TPM2 primer set (461 bp, Tm: 
64ºC) forward primer, gctcgctagcctcgagCGGTCCCTGCGCCCGGGCAGC and reverse 
primer, cgccgaggccagatctGTGAGGACCGGACGGACTGGGCTGGG following standard 
PCR conditions with the modification of   7-deaza-2’-deoxyguanosine 5’-triphosphate 
(dc7GTP) being added.  For TNNC2, genomic DNA from a control sample was amplified 
using the primer set (1625 bp, Tm: 65ºC), forward primer, 
gctcgctagcctcgagCCCTCACCCTTTGGCACCCTG and reverser primer, 
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cgccgaggccagatctGGTGACCGGGACTCCTCTGTTG following standard PCR conditions.  
All constructs were sequenced and compared to the NCBI consensus sequence 
(http://www.ncbi.nlm.nih.gov) using Sequencher v4.8 (Gene Codes, Ann Arbor, MI).  The 
400 bp HOXA9 promoter construct was obtained from Dr. Chandrashekhar V. Patel and 
construct design is described in Trivedi et al., 2008211. 
6.2.4 Generation of regulatory SNP with promoter constructs 
Potential regulatory SNPs in TPM1, TPM2, TNNC2 and HOXA9 that differed in 
allele-dependent DNA-binding ability through the EMSAs were further evaluated to 
determine their effect on promoter activity.  The ancestral and alternate 20mers for each 
SNP used in the EMSA were redesigned to incorporate 5’-KpnI and 3’-XhoI cut site 
overhangs to allow for direct ligation into the front of double digested corresponding 
promoter vector (described above).  The ancestral allele of rs3801776 was within the 400 bp 
HOXA9 construct. Site-directed mutagenesis was used to create the HOXA9 alternate allele 
construct using QuikChange® II following manufacturer’s protocol (Agilent Technologies, 
Santa Clara, CA). 
6.2.5 Evaluation of common TPM1 haplotypes on skeletal muscle TPM1 isoform 
promoter activity 
6.2.5.1 Identification of common TPM1 haplotypes 
 A 1,774 base pair region containing eight TPM1 SNPS was obtained from Savill et 
al.199  To establish TPM1 haplotype frequency in the general population (control), genotype 
data was obtained from the 1000 genome project 
(http://browser.1000genomes.org/index.html) for each of the eight TPM1 SNPs in the 1,774 
base pair region.   Individuals of Mexican Ancestry (MXL), obtained from the 1000 genome 
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project, were used as controls for our Hispanic cases that were also of Mexican ancestry.  To 
establish TPM1 haplotype frequencies in our clubfoot dataset, DNA from 64 nonHispanic 
White (NHW) probands (28 multiplex (+FH) and 36 simplex (─FH)) and 73 Hispanic 
probands (21 multiplex (+FH) and 52 simplex (─FH)) were sequenced.  Two primers sets 
(set 1 (940 bp, Tm: 63°C): forward primer, ACTCACCTGAAACTGACCTTCCCA; reverse 
primer, AAGTCACGCAGCAGGAAACTAGGA; set 2: (1,281 bp, Tm: 56°C): forward 
primer, ATGGGCCTCAGCCTGACTCTTAAA; reverse primer, 
AACGGGTGGTGTTGAGAAGGTTCT) were designed to amplify the ~1.7 kb TPM1 
region using standard PCR conditions.  Sequences were compared to the NCBI consensus 
sequence (http://www.ncbi.nlm.nih.gov, NM_001018005.1).  Genotype data was inputted 
into Haploview to generate the common haplotypes in the case and control populations150. 
6.2.5.2 Evaluation of TPM1 haplotypes on promoter activity 
Previously, Savill et al. found that 3 SNP haplotypes within a ~1.7 kb region 
upstream of the short TPM1 isoform differentially affected expression199.  We evaluated the 
four common TPM1 haplotypes for effect on promoter activity of the skeletal muscle TPM1 
isoform.  Common haplotype 2-4 inserts were obtained through XhoI and SacI double 
digestion of the constructs of Savill et. al using standard techniques (see Savill et. al, 2010 
for construct designs)199.  Inserts were ligated into the double digested skeletal TPM1 
promoter construct (Figure 6.2A).  Site-specific mutagenesis was used to create the TPM1 
haplotype 1 (Table 6.2) using QuikChange® II following the manufacturer’s protocol 
(Agilent Technologies, Santa Clara, CA).   
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6.2.6 Luciferase assays 
C2C12 cells (100,000 cells/well) were seeded in 12-well plates for 24 hrs before 
transfection.  For transfection, 1.12 µg of luciferase reporter construct, .048 µg of Renilla 
internal control and Opti-MEM were incubated with FuGENE HD (Promega, Madison, WI) 
following the manufacturer’s protocol.  All experiments were performed in triplicate and 
repeated three independent times.  For undifferentiated C2C12 cells, luciferase activities 
were determined 48 hrs after transfection using the dual-luciferase system (Promega, 
Madison, WI).  For differentiated C2C12 cells, 48 hours after transfection the media was 
replaced with DMEM medium supplemented with 2% horse serum (Life Technologies, 
Grand Island, NY) and five days later luciferase activities were determined.  Unpaired t-tests 
were used to compare luciferase expression between constructs. 
6.2.7 Comparison of allelic variation (genetic signature) across genes 
Genotype data for rs3801776/HOXA9, rs2025126/TPM2, rs2145925/TPM2 and 
rs4075583/TPM1 from 258 NHW and 288 Hispanic clubfoot probands and controls 
including 174 NHW (CEU+GBR) and 66 Hispanic (MXL) individuals was entered into 
Haploview150. The custom analysis tool in Haploview was used to generate the common 
genetic signatures.  Associations between clubfoot and each gene, on its own and along with 
the other genes (as factors within an additive model), were assessed using logistic regression 
models.  Odds ratios and confidence intervals were calculated separately for NHW and 
Hispanics. Additionally, the allelic burden within each study subject was evaluated by 
summing the alleles (0 for homozygous ancestral allele, 1 for homozygous alternate allele 
and 2 for heterozygous allele).  Mann-Whitney U tests were used to compare the allelic 
sums between case and controls (stratified by ethnicity). 
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Table 6.1.  Probes used in EMSAs 
*Ancestral allele listed first based on NCBI CEU listing   
Gene SNP Forward oligo* Reverse oligo*
TPM1 rs4075583 ATTCTTGC[G/A]GTTGGGATCA CCTGATCCCAAC[C/T]GCAAGAAT
TPM1 rs4075584 CTCTGGCTCC[T/C]GGGCATG CCCATGCCC[A/G]GGAGCCAGAG
TPM1 rs73431508 AGAAGTGG[A/G]AGCCAGAGC GGGCTCTGGCT[T/C]CCACTTCT
TPM1 rs79854225 GCCAGACACCC[G/A]GTTCCC GGGGGAAC[C/T]GGGTGTCTGGC
TPM1 rs111470259 GGACAGCCGCGG[C/T]AGCCG CCCGGCT[G/A]CCGCGGCTGTCC
TPM1 rs4075047 GGAAGTCGC[G/A]GCCTCCAG CCCTGGAGGC[C/T]GCGACTTCC
TPM1 rs76273871 GAGCCCCAGGGAG[G/A]CTGGC GGCCAG[C/T]CTCCCTGGGGCTC
TPM1 rs57645645 AACCTGA[G/A]GAGAAAAAGC GGGCTTTTTCTC[C/T]TCAGGTT
TPM1 rs3809565 CTATTAAC[A/G]AGACCCTCA GGTGAGGGTCT[T/C]GTTAATAG
TPM2 rs2025126 GGACAGAGT[G/A]GCTGGATG CCCATCCAGC[C/T]ACTCTGTCC
TPM2 rs2145925 GGCTACTGGGA[T/C]GGAAGC CCGCTTCC[A/G]TCCCAGTAGCC
TNNC2 rs383112 GCACTGGGGAG[T/C]AGGCAA CCTTGCCT[A/G]CTCCCCAGTGC
TNNC2 rs437122 GTCGGAGGC[T/C]GTCAGCTT GGAAGCTGAC[A/G]GCCTCCGAC
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6.3 Results 
6.3.1 The allele-specific transcription factor binding site of rs4075583/TPM1 does not 
influence TPM1 promoter activity.  
In previous studies, we described associations between four TPM1 SNPs and 
clubfoot179.  Two of these associated SNPs, rs3809565 and rs4075583 are located upstream 
or within the first intron of TPM1, respectively, which are potential regulatory regions.  In 
silico analysis predicted allele-specific transcription factor binding affinity for rs4075583 
and rs3809565, this could lead to changes in transcription.  Using undifferentiated and 
differentiated C2C12 (mouse muscle cells) nuclear extracts, EMSAs were used to test the 
allele-dependent presence of different transcription factor binding sites for each SNP.  As 
shown in Figure 6.1B, the ancestral allele of rs4075583/TPM1 produced a DNA-protein 
complex in both the undifferentiated and differentiated nuclear extracts, while 
rs3805965/TPM1 did not show allele-specific binding (data not shown). 
Luciferase assays were used to assess whether the allele-specific binding of the 
20mers containing the ancestral and alternate alleles of rs4075583/TPM1 could influence 
promoter activity in either undifferentiated or differentiated C2C12 cells.  As shown in 
Figure 6.1C and D, although a significant increase in promoter activity was found when the 
rs4075583/TPM1 20mers were upstream of the TPM1 promoter construct, there was no 
significant difference in activity between the ancestral and alternate alleles.  These results 
suggest that the genomic region containing rs4075583 influences promoter activity but the 
allele-dependent transcription factor binding site does not significantly alter promoter 
activity. 
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6.3.2 The allele-specific transcription factor binding site of rs4075583 in the context of 
haplotypes significantly decreases TPM1 promoter activity.  
Savill et al. (2010) previously reported that three SNPs, rs4075583, rs4075584 and 
rs4075047, in a ~1.7 kb 5’ upstream region of the short form of TPM1 show differential 
expression dependent on cell type and specific haplotype199.  Although the ancestral and 
alternate forms of rs4075583/TPM1 showed no significant difference in promoter activity, 
we evaluated the ~1.7 kb region that contains rs4075583 and seven additional SNPs in the 
context of a haplotype for effect on promoter activity of the skeletal muscle TPM1 isoform 
in C2C12 mouse muscle cells.  We identified the most common TPM1 haplotypes in control 
and clubfoot datasets.  As shown in Table 6.2, haplotype 1 was the most common in both 
ethnicities for both cases and controls.  The second most common haplotype was haplotype 
2 in NHWs and haplotype 3 in Hispanics.   This supports the importance of treating each 
ethnicity individually.  Before assessing the impact of these four haplotypes on the promoter 
activity of the skeletal muscle TPM1 isoform, EMSAs were performed on the seven 
additional TPM1 SNPs to evaluate for allele-dependent transcription factor binding sites. No 
DNA-protein complexes were observed with any of these SNPs (data not shown).  However 
as shown in Figure 6.2B and C, the haplotype constructs with all eight SNPS significantly 
affected promoter activity.  Haplotype 1 with the alternative form (A) of rs4075583/TPM1 
produced the greatest expression.  In contrast, haplotypes 2-4 with the ancestral allele (G) of 
rs4075583 showed significant decreased promoter activity (Figure 6.2B and C).   
Interestingly, haplotype 3, which produces the least promoter activity, has the most allelic 
variation with five different variants compared to haplotype 1 which was the most common.  
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These results suggest that evaluation of individual SNP expression does not provide a 
complete functional assessment. 
6.3.3 The allele-specific transcription factor binding affinity for rs2025126 and rs2145925 
influences TPM2 promoter activity. 
Previously, we reported associations between five TPM2 SNPs and clubfoot179.  Two 
SNPs are located in potential regulatory regions, rs2025126, upstream and rs2145925 in 
intron 2 of TPM2   In silico analysis predicted the presence of allele-dependent transcription 
factor binding sites for each SNP.  As shown in Figures 6.3B and 6.4B, only the ancestral 
allele of rs2025126/TPM2 created a DNA-protein complex, while rs2145925 created two 
DNA-protein complexes associated with the presence of the alternate allele.  Figures 6.3 and 
6.4 show that the 20mers of rs2025126 and rs2145925 increase TPM2 promoter activity, 
suggesting that these SNPs have a regulatory function.  While the transcription factor 
binding affinity of the ancestral allele of rs2025126 increased promoter activity in 
differentiated cells, no significant effect on promoter activity was found in undifferentiated 
cells (Figure 6.3C and D).  Interestingly, the binding affinity of the alternate allele of 
rs2145925/TPM2 that creates two DNA-protein complexes caused different effects on 
promoter activity during the different myogenesis stages used in this study (Figure 6.4C and 
D).  The transcription factors binding associated with the alternate allele of 
rs2145925/TPM2 caused a decrease in promoter activity with the undifferentiated cells, 
while an increase in activity was found with differentiated cells (Figure 6.4C and D).  These 
results for TPM2 SNPs suggest that the allele-dependent presence of different transcription 
factor binding sites could play key roles during specific stages of myogenesis.  
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6.3.4 The allele-dependent DNA-binding ability of rs437122/TNNC2 creates a DNA-
protein complex that does not influence promoter activity.  
Previously, we reported a genotypic effect with rs383112/TNNC2 and gene 
interactions with rs437112/TNNC2 and clubfoot179.  In silico analysis of these SNPs 
suggested that allele-specific transcription factor binding sites differed between alleles for 
each SNP.   As shown in Figure 6.5B, a DNA-protein complex was generated with the 
ancestral allele of rs437122/TNNC2.   None were formed with rs383112/TNNC2 (data not 
shown).  As observed previously with the other SNPs, inclusion of the ancestral and 
alternate 20mers upstream of the promoter produced significant increased activity (Figure 
6.5C).  However, even with allele-specific DNA-protein complex observed in the EMSA 
(Figure 6.5B), no significant difference in promoter activity was found between the alleles 
of the SNP (Figure 6.5B). 
6.3.5 The allele-dependent transcription factor binding of rs3801776/HOXA9 influences 
promoter activity.  
Previously, we found that rs3801776, a SNP located in the basal promoter of 
HOXA9, was significantly associated with clubfoot 127.  This is important because HOXA9 
plays a role in muscle patterning and development124.  As shown in Figure 6.6B, the 
ancestral allele of rs3801776/TNNC2 created a DNA-protein complex that was not present 
with the alternate allele.    A four hundred base pair HOXA9 construct containing the basal 
promoter of HOXA9 where rs3801776 is located was used to evaluate rs3801776 effect on 
promoter activity.  This construct is described in Trivedi et al.211.   As shown in Figure 6.6C 
and D, for both undifferentiated and differentiated muscle cells a significant decrease in 
expression was associated with the alternate allele-dependent non-transcription factor 
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binding site.  These results suggest that the differing allele-dependent transcription factor 
binding of rs3801776/HOXA9 has a regulatory function that affects HOXA9 expression. 
6.3.6 Genetic signature across genes is shared by both cases and controls. 
We found that allelic variation in three SNPs, rs3801776/HOX9, rs2025126/TPM2 
and rs2145925/TPM2 altered promoter activity.  In addition, the ancestral allele of 
rs4075583/TPM1 altered promoter activity in the context of a haplotype.  We asked whether 
different allelic combinations (genetic signature) of these four SNPs differed between cases 
and controls.  As shown in Table 6.3, no difference was found between the case and control 
groups for either ethnicity.  However, there were differences in frequency between the NHW 
and Hispanics for the genetic signatures providing additional support for the importance of 
evaluating each ethnicity separately. 
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Figure 6.2.  Functional analysis of four common TPM1 haplotypes.  (A) A 1,774 bp 
TPM1 fragment was inserted in front of the 500 bp TPM1 promoter construct.  The 
haplotype constructs were co-transfected with a Renilla reporter construct (pGL4.73) into 
C2C12 undifferentiated (B) and differentiated (C) cells.  Luciferase and Renilla activities of 
cell extracts were determined and luciferase activities were normalized to the Renilla 
activity to correct for variation in transfection efficiencies.  The data represents the mean 
values ±SD from three independent experiments done in triplicate.  Unpaired t-tests were 
used to compare luciferase expression between haplotype constructs. Decrease in luciferase 
expression observed when the ancestral allele of rs4075583 is present in the haplotype (2-4).    
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Figure 6.4.  Functional analysis of rs2145925/TPM2.  (A) Luciferase constructs were 
designed to incorporate 500 base pairs upstream of the transcriptional start site of the TPM1 
skeletal muscle isoform (promoter construct).  The ancestral and alternate luciferase 
constructs were generated by using the twenty base pair double stranded oligonucleotides 
that incorporated either the ancestral or alternate allele used in the EMSA and ligating them 
in front of the TPM1 promoter construct. (B) 32P-labeled double stranded oligonucleotides 
incorporating either he ancestral or alternate allele of rs4075583 were incubated with 
undifferentiated (undif.) (4.5 µg) and differentiated (dif.) (5.00 µg) C2C12 nuclear extract.  
Asterisks indicate DNA-protein complexes.  Arrow shows nonspecific band in EMSAs 
performed with undifferentiated nuclear extract. (C and D) Luciferase test constructs were 
co-transfected with a Renilla reporter construct (pGL4.73) into C2C12 undifferentiated (B) 
and differentiated (C) cells.  Luciferase and Renilla activities were determined and luciferase 
activities were normalized to the Renilla activity to correct for variation in transfection 
efficiencies.  The data represents the mean values ±SD from three independent experiments 
done in triplicate.  Unpaired t-tests were used to compare luciferase expression between the 
ancestral and alternate constructs.  The alternate allele creates two DNA-protein complexes 
that significantly affect luciferase expression in both undifferentiated and differentiated 
muscle cells. 
*: 0.01<p<0.05, **: p<0.01: Unpaired t-test results for comparison to promoter construct 
Undif: undifferentiated; Dif: differentiated. 
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Figure 6.6.  Functional analysis of rs3801776/HOXA9.  (A) The HOXA9 luciferase 
construct was obtained from the Patel lab and incorporated rs3801776 within the 400 base 
pair promoter region.  Site-specific mutagenesis was utilized to create the alternate allele 
luciferase construct. (B) 32P-labeled double stranded oligonucleotides incorporating either 
the ancestral or alternate allele of rs3801776 were incubated with undifferentiated (4.5 µg) 
and differentiated (5.00 µg) C2C12 nuclear extract.  Asterisks indicate DNA-protein 
complexes.  Arrow depicts nonspecific band in gel shift assays performed with 
undifferentiated nuclear extract. (C and D) The HOXA9 basal promoter construct 
incorporates the ancestral allele of rs3801779.  Site-specific mutagenesis was used to create 
the alternate allele construct.  The test constructs were co-transfected with a Renilla reporter 
construct into C2C12 undifferentiated (B) and differentiated (C) cells.  Luciferase and 
Renilla activities were determined and luciferase activities were normalized to the Renilla 
activity to correct for variation in transfection efficiencies.  The data represents the mean 
values ±SD from three independent experiments done in triplicate.  Unpaired t-tests were 
used to compare luciferase expression between the ancestral and alternate constructs.  The 
ancestral allele creates a DNA-protein complex that significantly decreases luciferase 
expression in both undifferentiated and differentiated muscle cells. 
Undif: undifferentiated; Dif: differentiated. 
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Table 6.3. Genetic Signatures* 
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6.4 Discussion 
Clubfoot is characterized by the inward posturing of the foot in a rigid, downward 
position, almost as if the foot is constrained in a contracted state1.  Calf muscle hypoplasia is 
generally universal and is persistent even after corrective treatment2,3.  This constellation of 
anomalies suggested a role for limb patterning and skeletal muscle genes in clubfoot.  In 
previous studies, HOXA and HOXD gene clusters and fifteen muscle contraction genes were 
interrogated leading to the identification of multiple associations127,179.  The majority of 
these associated SNPs were located in potential regulatory regions, which could lead to 
allele-dependent transcription factor binding sites that could affect gene expression.  To 
determine if any of these SNPs have regulatory function, we functionally assessed seven 
potential regulatory SNPs in four of our strongest associated genes, TPM1, TPM2, TNNC2 
and HOXA9.   
Five SNPs, rs3801776/HOXA9, rs2025126/TPM2, rs2145925/TPM2, 
rs437122/TNNC2 and rs4075583/TPM1, showed allele-dependent transcription factor 
binding sites that differed between ancestral and alternate alleles by EMSA. To determine 
effect on promoter activity, each SNP, in the context of a 20mer, was tested by ligating it in 
front of its corresponding promoter construct and expressed in biologically relevant C2C12 
muscle cells. Because muscle development occurs in two stages with cells beginning as 
myoblasts (undifferentiated) and developing into myotubes (differentiated), requiring 
different transcription factors during each stage, these experiments were performed during 
both muscle stages41.  The incorporation of each 20mer caused an increase in luciferase 
activity suggesting that these genomic regions have regulatory function. 
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Previously, we found associations with SNPs in the HOXA gene cluster and 
clubfoot127.  The strongest association was with rs3801776, a SNP located in the basal 
promoter of HOXA9127.  The ancestral allele of rs3801776 creates a DNA-protein complex 
that lead to an increase in promoter activity (Figure 6.6B-D).  HOXA9 is a member of the 
homeobox A gene cluster, a group of transcription factors expressed in fore- and hindlimb 
muscles that are involved in patterning and differentiation of muscles in both embryonic 
limbs and adult limbs during muscle repair124.  The HOXA genes are also known to regulate 
the synchronized development of muscles, tendons and cartilages124,212.  Mutations in these 
genes cause mammalian limb abnormalities162,164.  In mice, Hoxa13 mutations cause 
hypodactyly, while deletion of Hoxa13 causes absence of the autopod162,213.  Therefore, 
enhanced promoter activity associated with rs3801776 may alter muscle patterning by 
altering slow and fast-twitch muscle designations, ultimately causing changes in muscle 
function. 
Previously, we found genotypic effects with rs383112/TNNC2 and significant gene 
interactions with rs437122/TNNC2, both SNPs located in potential TNNC2 regulatory 
regions179.  TNNC2 encodes troponin C and plays a role in initiating muscle contraction in 
fast-twitch muscle fibers binding Ca2+183.  This causes a conformational change in troponin I, 
which releases inhibition of troponin T causing tropomyosin to allow actin-myosin 
interactions183,195.  No allele-dependent transcription factor binding sites were observed for 
rs383112, located upstream of TNNC2.  Although rs437122 located in intron 1 of TNNC2 
showed an allele-dependent transcription factor binding site with the ancestral allele, 
however, this binding site did not affect promoter activity (Figure 6.5B and C).  While 
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neither SNP showed altered gene expression, they may tag for other SNPs in the region that 
could affect the regulation of TNNC2.  
Previously, we found associations with four SNPs in two members of the 
tropomyosin family, TPM1 (fast-twitch muscle) (rs3805965 and rs4075583) and TPM2 
(slow-twitch muscle)  (rs2025126 and rs2145925)179.  Tropomyosin functions with the 
troponin complex to regulate muscle contraction by restricting myosin from binding to 
actin183.  The upstream SNP, rs3805965/TPM1 did not incorporate a transcription factor 
binding site for either allele (data not shown) suggesting that this associated allele could be 
tagging for a causative allele, thus investigating the region that is in linkage disequilibrium 
with this allele needs to be assessed for other potential regulatory SNPs.   
Although functional analysis of rs3805965 yielded no potential regulatory effects, 
rs4075583, located in intron 1 of the TPM1 skeletal muscle isoform, showed evidence for a 
role in regulation of TPM1 promoter expression (Figure 6.1 and 6.2).  A previous study by 
Savill et. al (2010) investigating the cause of Metabolic syndrome, described a ~1.7 kb 
region containing three SNPs, rs4075583, rs4075584 and rs4075047, that influenced the 
expression of TPM1199.  Expression varied by haplotype and cell type with those studies 
focusing primarily on the cytoskeletal TPM1 isoform in HEK293 and THP-1 cells199.  
Interestingly, different isoforms of TPM1 are produced by alternate splicing and are 
expressed only in specific cell types.  Our studies focused on the skeletal muscle TPM1 
skeletal isoform, which requires a different promoter for expression.  We first assessed 
whether rs4075583 as a 20mer could influence the promoter activity.  Although the an 
allele-dependent transcription factor binding site was found with the ancestral allele, no 
effect on promoter activity was found.  Based on Savill’s finding of specific haplotypes 
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influencing expression and that the ~1.7 kb region contains rs4075583, and seven additional 
SNPs being in a conserved region, we assessed whether rs4075583 in the context of a 
haplotype could affect promoter activity199.  The four common haplotypes evaluated differed 
in effect on promoter activity, even though the seven additional SNPs did not incorporate 
transcription factor binding sites, thus these SNPs may influence the binding stringency of 
the transcription factor associated with the ancestral allele of rs4075583.  The most common 
haplotype that contains the alternate allele of rs4075583 eliminates a transcription factor 
binding site and increases promoter activity suggesting that through evolution this allele 
may have become important for skeletal muscle function in humans (Figure 6.1B and 6.2).  
Indeed, the ancestral allele (G), which was invariant in haplotypes 2-4, significantly 
decreased promoter activity.  Interestingly, haplotype 3 incorporates the alternate allele for 
five of the eight SNPs resulting in the greatest decrease in promoter activity (Table 6.2 and 
Figure 6.2B and C).  These findings suggest the importance of this region for TPM1 gene 
regulation, in particular the conservation of these seven additional TPM1 SNPs and the 
necessity of the evolved alternate allele of rs4075583 to obtain the required expression of 
TPM1 for muscle function.  However, to begin to delineate the SNPs contributing to gene 
regulation, individual analysis of each SNP is needed and will be the focus of future studies. 
Interestingly, evaluation of two SNPs in TPM2, rs2025126 and rs2145925, suggests 
the importance of these SNPs for gene regulation at different stages of myogenesis. 
rs2025126, located upstream of TPM2, creates a DNA-protein complex with both 
undifferentiated and differentiated nuclear extracts (Figure 6.3B), however, promoter 
activity was only increased in differentiated cells (Figure 6.3D).  As was found with 
rs2145925, the alternate allele incorporated two DNA-protein complexes that increased 
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activity in undifferentiated cells (Figure 6.4B and C), while decreasing in differentiated cells 
(Figure 6.4D).  Myogenesis requires different transcription factors during different stages of 
development such as when myoblast fate (undifferentiated) determination is occurring and 
during subsequent muscle function (differentiated).  Specification of when and where 
myogenic cells form slow- or fast-twitch muscle fibers has been an ongoing debate, with 
some models suggesting the cells are predisposed to a slow or fast fate41,49-58.  Utilizing this 
model, it can be postulated that one of the factors binding with the alternate allele of 
rs245925 is involved in regulating the specification of the myoblast (undifferentiated) to 
become a slow-twitch muscle fiber.  Once at the differentiated state when muscle functions 
such as contraction occur, the factors associated with rs2025126 and rs2145925 that caused 
increase promoter activity could be required for regulating muscle contraction and the 
decrease in activity with the alternate alleles could lead to dysregulation of muscle 
contraction.  This dysregulation could lead to the foot being stuck in a contracted state as 
observed with clubfoot. 
Muscle development and function are multi-faceted processes involving various 
proteins.  Dysregulation during either process could cause a cascade of effects resulting in 
muscle anomalies such as muscle hypoplasia, which is observed with clubfoot.  For 
example, HOX genes regulate LBX1, a transcription factor that is important in the migration 
of muscle precursor cells into the developing limb bud (Figure 6.7A)214.  HOXA9 
misexpression could affect LBX1 expression causing a decrease in cell migration leading to 
muscle hypoplasia as seen in clubfoot individuals (Figure 6.7B).  In addition, it has been 
suggested that the first muscle precursor cells to enter the limb bud are intended to form the 
slow-twitch muscle fibers with the fast-twitch muscle fibers being secondary215.  
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Misexpression of HOXA9 could affect the muscle composition of the limb, which has been 
observed with some clubfoot individuals having disorganization of muscle fibers.  With the 
disorganization of the muscle fibers in combination with misexpression of TPM1 and TPM2, 
genes important in regulating muscle contraction, a persistent contracted state of the foot 
could occur as characterized with clubfoot (Figure 6.7C).  With these hypothetical pathways 
contributing to the key characteristics of clubfoot, persistent contracted state and calf muscle 
hypoplasia, we asked whether there were differences in allelic combinations (genetic 
signature) of these four SNPs/genes in cases compared to controls.  This is based on the 
multifactorial model which states that variation in multiple genes contribute to quantitative 
traits and common birth defects93,108,110.  This approach has been successfully applied to the 
folate pathway genes and has been used in spina bifida to identify genetic risk signatures for 
different ethnicities 216.  Using a less stringent analysis (Haploview) than the one employed 
in the spina bifida study, we identified genetic signatures for our case and controls groups by 
ethnicity (Table 6.3).  However, the frequency of the most common genetic signatures did 
not differ between cases and controls for either ethnicity (Table 6.3).  While these specific 
genetic signatures did not appear to contribute to clubfoot, other regulatory variants within 
these genes cannot be excluded from playing a role. 
The goal of this study was to assess the expression of potential muscle-specific 
regulatory variants that had previously been associated with clubfoot.  We found that five 
SNPs, rs3801776/HOXA9, rs2025126/TPM2, rs2145925/TPM2, rs4075583/TPM1 and 
rs437122/TNNC2, showed allele-dependent transcription factor binding sites but only the 
first three also altered promoter activity.  However, rs4075583/TPM1, in the context of the 
different DNA sequence/haplotypes, had varying effects on promoter activity.  Although 
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delineating the individual TPM1 SNPs within the ~1.7 kb region that regulate promoter 
activity is needed, our results suggest that future expression analyses of potential promoter 
variants should be performed in the context of the in vivo DNA sequence also.  Finally, 
although a genetic signature incorporating these four SNPs was not identified, this approach 
of analyzing variants within genes in a common pathway such as muscle development, 
patterning and/or function could begin to identify genetic signatures for clubfoot.   
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7.1 Summary and future studies 
Clubfoot is a common birth defect affecting more than 135,000 newborns world-
wide each year66-71,107.  Even with corrective treatment during the first few years of life, 
residual foot and leg abnormalities persist77,78.  A genetic etiology is suggested based on 
familial recurrences and segregation analyses, although Mendelian inheritance does not 
explain these recurrences.  Environmental factors have also been implicated with maternal 
smoking having the most consistent association.  Based on these findings clubfoot has been 
posited to fit a multifactorial model with both genetic and environmental factors 
contributing to causation 69,71,101,106,110.  Identifying the genetic factors has been a challenge.  
The overall goal of these studies was to identify the genetic variation contributing to 
clubfoot.  We describe the use of a candidate gene approach wherein we interrogated limb 
and muscle-specific genes and found associations with regulatory variants in HOXA9, 
TPM1, TPM2 and TNNC2.  We extended those studies by performing functional analyses on 
these SNPs to determine whether the allelic forms of these SNPs alter promoter expression.  
We hypothesized that variation in these SNPs can perturb gene expression; individually they 
may not affect foot development but in aggregate they may alter the final outcome.   We 
also describe the use of whole genome linkage and association analyses on ten multiplex 
clubfoot families and our success in identifying new regions to interrogate in future studies. 
 Chapter 1 provides an overview of clubfoot from a clinical description to 
approaches currently being employed to identify genes contributing to clubfoot.  Chapter 3 
discusses the results of studies interrogating limb patterning genes, HOXA and HOXD gene 
clusters, and IGFBP3121,127. As shown in Figure 3.1, the results of these studies allowed us 
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to begin filling in a model wherein functional perturbation of these genes contributes to 
clubfoot. The work on HOXA9 continued and is discussed in Chapter 6. 
Chapter 4 presents the results of our genome-wide linkage scan performed on 10 
multiplex clubfoot families.  Eight regions were identified: 3q22.1-q24, 4p14, 4q32.1, 
14q13.1, 14q32.12, 17q21.33-q22, 17q23.2-q24.2 and 20q13.12.  Only one of these regions, 
17q23.2-q24.2, has been previously implicated in clubfoot118.   TNNC2 is in 20q13.12 and is 
a candidate gene because of its role in muscle contraction.  Sequencing of the coding region 
did not identify any mutations or rare variants likely to cause disease.  This gene still 
remains of interest because the promoter region has not been completely interrogated and 
needs to be assessed further.  These new regions provide areas to data mine for clubfoot 
genes.  Further validation of these regions in our complete clubfoot dataset needs to be 
performed in order to narrow down these regions.  
Chapter 5 describes the interrogation of muscle contraction genes that cause Distal 
Arthrogryposis syndromes.  Many of these conditions have clubfoot as an associated finding 
with multiple congenital joint contractures.  Strong associations were found for SNPs in 
TPM1 and TPM2 in single SNP, haplotype and gene interaction analyses and were the first 
to identify genotypic effect with TNNC2 SNPs.  Interestingly, these associated SNPs were 
located in potential regulatory regions suggesting gene regulation may play an important 
role in the etiology of clubfoot.  Based on these findings, future studies could focus on the 
additional genes known to play a role in muscle contraction through interrogation in our 
large clubfoot dataset. 
Chapter 6 presents the functional assessment of seven associated SNPs identified in 
studies described in Chapter 3 and 5.  All of these SNPs have a potential regulatory function 
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because they are located either in the promoter or enhancer/suppressor regions of HOXA9, 
TPM1, TPM2 and TNNC2.  Although rs3801776/HOXA9, rs2025126/TPM2 and 
rs2145925/TPM2 altered promoter activity, the specific binding protein needs to be 
identified which might lead to the identification of a common pathway and/or mechanism.  
Interestingly, one SNP, rs4075583/TPM1, altered promoter expression but only when in the 
context of the surrounding DNA environment containing seven other variants.  Therefore, in 
order to obtain a better functional assessment, all potential regulatory SNPs should be 
evaluated individually and should not be excluded without a haplotype functional analysis.  
The results of these studies present new areas for future clubfoot gene hunting and a 
paradigm for assessing regulatory variants.  Our results and a recent study suggest that gene 
regulation in limb development genes play a role in clubfoot180.  It also begins to define gene 
pathways, may allow us to identify at-risk genetic signatures and ultimately should be useful 
in population-based genetic screening for at-risk genotypes that predispose to clubfoot.  This 
would translate to improved genetic counseling for clubfoot families. 
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